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ABSTRACT 
Primary open-angle glaucoma (POAG) is a progressive optic neuropathy 
characterized by loss of peripheral vision secondarily associated with elevated intraocular 
pressure (IOP). Transforming growth factor (TGF)-β2 is markedly elevated in the 
aqueous humor (AH) of patients with POAG. It has been previously shown that TGF-β2 
increases IOP, in part, by inducing expression and release of endothelin-1 (ET-1) and 
connective tissue growth factor (CTGF) within the trabecular meshwork (TM). ET-1 and 
CTGF may ultimately lead to increases in IOP by enhancing TM cell contractility and 
extracellular matrix (ECM) deposition. Here we confirm that TGF-β2 enhances mRNA 
content of ET-1, CTGF, and various ECM components in cultured human TM cells. In 
addition, we demonstrate a dose- and time-dependent decrease in the bradykinin B2 
receptor expression in response to exogenous TGF-β2. This finding represents a novel 
mechanism by which TGF-β2 may elevate IOP through perturbation of the kallikrein-
kinin system. Despite these advancements, the direct effect of elevated IOP on TM cell 
responsiveness remains unknown. 
To accurately model and characterize the effect of elevated IOP on the TM in 
vitro, we designed and built a custom hydrostatic pressure chamber. Cultured human TM 
cells exposed to elevated hydrostatic pressure exhibit decreased viability, accumulation 
of F-actin, and selective changes in the expression of matricellular and structural ECM 
genes associated with the pathogenesis of POAG including TGF-β2, ET-1, and CTGF. 
	xv 
Furthermore, secreted ET-1, in response to elevated hydrostatic pressure, acts in an 
autocrine manner through the ETB receptor to enhance TGF-β2 and ppET-1 mRNA, but 
not CTGF content. The mechanism(s) by which TM cells sense and respond to elevated 
hydrostatic pressure remain unknown, but findings presented here suggest that neither 
activation of mechanosensitive TRPV channels nor oxidative stress is involved. Finally, 
we demonstrate that a second form of mechanical stimuli, fluid sheer stress as a result of 
increased perfusion flow rate in the anterior segment perfusion assay, can also influence 
both CTGF and ppET-1 mRNA content in the TM in situ.  
Taken together, these results support the hypothesis that pressure-dependent 
changes in TM cell gene expression represent a feed-forward mechanism that 
exacerbates TGF-β2 associated increases in TM cell contractility and altered ECM 
synthesis and deposition in affected POAG patients.			
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CHAPTER 1 
LITERATURE REVIEW 
 
Primary Open-Angle Glaucoma. 
Glaucoma is a leading cause of irreversible blindness, affecting nearly 65 million 
people worldwide. This number is expected to rise to 112 million by the year 2050.1, 2 In 
the US alone, glaucoma healthcare expenses exceed 1.9 billion annually.3 This number 
likely underestimates the true socioeconomic impact of this disease as many Americans 
in the early, asymptomatic stages of glaucoma remain undiagnosed.5 Glaucoma can be 
broadly subdivided into angle-closure and open-angle pathologies. In patients with angle-
closure glaucoma, the angle between the iris and cornea is constricted as a result of 
trauma or inflammation. This produces a marked and rapid increase in intraocular 
pressure (IOP) leading to blurred vision and acute pain. Angle-closure glaucoma is less 
prevalent, effecting only 26% of patients and is often asymmetric.2 In contrast, primary 
open angle glaucoma (POAG) is a slowly progressing form of glaucoma that is far more 
common (prevalence of 1.86% in individuals over the age of 45 in the United States 
alone),6 causes very little or no pain, and is typically bilateral. POAG begins with loss of 
peripheral vision and can culminate in irreversible blindness if left untreated. Currently, 
over 2.7 million Americans suffer from POAG with this number expected to more than 
2 
double to 6.3 million by 2050, highlighting the importance of advancing patient care 
(Figure 1). Regrettably, in patients with POAG the gradual loss of vision is often the first 
recognizable symptom. By the time visual deficits are perceived, however, extensive and 
profound injury to the optic nerve has occurred. Despite its overwhelming prevalence and 
socioeconomic impact, the treatment of patients with POAG remains limited and 
palliative.   
The Visual Pathway. 
 Perception of our visual world begins with the capture of a single photon of light 
(390-700 nm) by rod and/or cone photoreceptors, highly specialized neuroepithelial cells 
localized to the outer layers of the retina. Electrochemical changes initiated by light-
hyperpolarized photoreceptors are subsequently “processed” by second (bipolar, 
horizontal, amacrine) and third-order (retinal ganglion cell) neurons of the retina to yield 
discriminatory spatial and temporal contextual information about the visual field 
perceived. The unmyelinated axons of retinal ganglion cell neurons carrying “processed” 
information exit the eye through the optic disc at the lamina cribrosa, a discrete 
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Figure 1. The Prevalence of Glaucoma. Projections for the number 
of people in the United States estimated to have glaucoma in 2010, 
2030, and 2050. Adapted from https://nei.nih.gov/eyedata/glaucoma 
3 
anatomical pinch-point where axons become centrally myelinated forming cranial nerve 2 
(optic nerve). Within the eye, the unmyelinated axons of retinal ganglion cells are 
exposed to IOP. Upon exiting the eye however, the optic nerve is subjected to intracranial 
pressure (ICP) derived from cerebrospinal fluid in the subarachnoid area of the 
retrobulbar space. The difference between these two pressurized zones, known as the 
translaminar pressure gradient (TPG), is typically quite small (≈2.6 mmHg).7, 8  
 
Myelinated axons of the optic nerve collectively transfer visual information from 
each visual field in a topographically preserved orientation. On its way to the primary 
visual cortex, the optic nerve partially decussates at the optic chiasm (Figure 2) 
maintaining a precise topographic orientation of each point in our visual fields. The 
majority of decussated nerve fibers proceeds through the optic tract and terminate in one 
of six discrete layers within the lateral geniculate nucleus of the thalamus. From there, 
Figure 2. Schematic of the visual pathway. 
Schematic of the visual pathway adapted from 
reviewofoptometry.com 
4 
topographically preserved visual information travels along the optic radiations either 
below (Meyer’s loop) or above the lateral ventricles and terminate medially within the 
occipital lobe (primary visual cortex, Broadman’s area 17) of each hemisphere. 
 
Trabecular Meshwork and Intraocular Pressure. 
 The pathophysiology of optic nerve injury in POAG is unclear, but most likely is 
associated with the abnormal buildup of pressure within the eye. Whereas elevated IOP 
(>21 mmHg) is a recognized major risk factor for the initiation and progression of 
glaucomatous neuropathy, the initial cause of elevated IOP remains a poorly-understood 
hallmark of this disease.9, 10 IOP is maintained by a balance between the production and 
outflow from the eye of aqueous humor (AH), a clear CSF-like fluid that provides 
nutrients to the avascular tissues of the anterior and posterior chambers of the eye. The 
rate of AH turnover varies in a diurnal manner, but is estimated to average around 2.4 
µl/min.11  AH is actively secreted from the non-pigmented epithelium of the ciliary body 
into the posterior chamber, flows through the pupil into the anterior chamber before 
draining from the eye by either the conventional or uveoscleral pathway. In the 
uveoscleral pathway (Figure 3A), AH passively seeps between tissue spaces in the 
ciliary muscle into supraciliary and suprachoroidal spaces before finally draining through 
the sclera to episcleral tissue.12  The rate of AH drainage through the uveoscleral pathway 
is controlled by the contraction or relaxation of the ciliary body, and thus is relatively 
insensitive to pressure.12   
5 
 At the junction where the iris meets the cornea (iridocorneal angle) there is a 
unique anatomical structure composed of endothelial and smooth-muscle-like contractile 
cells resting on a series of fenestrated beams and sheets of extracellular matrix (ECM) 
called the trabecular meshwork (TM, Figure 3B).13, 14 
In the conventional outflow pathway, AH passes through the TM in a pressure-dependent 
manner, enters Schlemm’s canal (SC), where it runs through a series of collector ducts 
and eventually rejoins the vasculature at the episcleral vein. The conventional outflow 
pathway can be subdivided into three distinct anatomical regions (the uveal, corneoscleral 
and juxtacanicular (JCT) meshwork), each with unique morphology and function. Outer 
TM cells, near the uveal and corneoscleral regions, are phagocytic, acting as a sort of 
filter of AH.15 Due to their large intercellular spaces, these layers offer relatively little 
resistance to AH outflow. TM cells of the JCT region, however, are embedded in a dense 
layer of ECM proteins,16 and the majority of outflow resistance through the TM is 
Figure 3. Aqueous Humor Outflow. (A) Diagram of AH outflow pathways. Adapted from 
touchophthalmology.com (B) Scanning electron micrograph of the trabecular meshwork adapted from 
Histology of the Human Eye, An Atlas and Textbook. 
A. B. 
6 
attributed to the increased organization of ECM and decreased intercellular space in this 
area.17 The innermost cells of the JCT are directly adjacent to SC. The endothelial cells of 
SC form a monolayer with tight junctions generating additional resistance to AH outflow  
(an estimated 10%). 17 AH is thought to  enter the lumen of SC through trans- or 
paracellular pores that form in the endothelium of SC. Impaired formation of these 
components can result in increased resistance to AH outflow.18, 19   
  Maintenance of IOP at healthy levels is of critical importance to preserving the 
overall function and health of the retina and optic nerve. AH production is relatively 
insensitive to changes in pressure; thus, IOP is primarily regulated by resistance to AH 
outflow. Total AH outflow through the pressure-independent uveoscleral pathway 
decreases with age and has been reported to account for as little as 10% of total outflow 
in elderly (>60 years of age) patients.20, 21 Consequently, only the conventional pathway 
is considered relevant to normal IOP maintenance.22 Elevated IOP, due to enhanced 
resistance to AH outflow through the TM, is transduced to the posterior segment of the 
eye eliciting optic nerve damage, retinal ganglion cell death, and visual deficits.23 A small 
but significant percentage of patients with POAG (15-25%) do not develop elevated 
IOP.8 This form, termed normal-tension glaucoma (NTG), may have a unique 
pathophysiology independent of elevated IOP. Both POAG and NTG patients, however, 
tend to exhibit ICPs that are 3-4 mmHg lower than healthy control subjects as well as 
similar morphologic changes in the optic nerve head, suggesting that the imbalance 
between IOP and ICP may play an important role in glaucomatous damage.7, 24 
Supporting this hypothesis,  reduction of IOP in NTG patients has been shown to 
decrease the risk of long-term progression.25  
7 
Therapeutic Management of POAG. 
 Current therapeutic options for the management of patients with POAG include 
both surgical and pharmacological strategies consisting of non-specific forms of 
intervention designed to lower IOP.26, 27  Carbonic anhydrase inhibitors, such as the 
acetazolamide Diamox, reduce IOP by attenuating AH production from the epithelium of 
the ciliary body processes.28 Beta-adrenergic antagonists, such as Timolol, inhibit AH 
secretion by limiting the synthesis of cyclic adenosine monophosphate (cAMP).29 
Latanoprost, a prostaglandin F2α analog, increases uveoscleral outflow by decreasing the 
expression of connective tissue within the ciliary body and enhancing the secretion of 
matrix metalloproteinase (MMPs) leading to remodeling of the extracellular matrix. 30-32  
 Regrettably, to date, there is no FDA-approved therapeutic strategy that primarily 
targets the conventional outflow pathway. In many cases, patient IOP cannot be 
controlled by a single medication and often requires the use of 3 or more different classes 
of drugs. Reported limitations of pharmacological options include decreased efficacy 
over time, limited bio-availability, and the need for frequent dosing. Surgical intervention 
is often required, including selective laser trabeculoplasty or trabeculectomy, to clear 
portions of obstructed TM. While this intervention does produce an immediate and 
marked drop in IOP, intraocular pressure often rebounds to pathological levels. Thus, 
while non-specific therapies that lower IOP do show limited success in slowing the 
progression of POAG, they are not sufficient to completely halt its advancement. The 
development of therapeutic strategies that specifically target the pathogenic causes of 
elevated IOP are critically needed to advance the care of affected patients.  
 
8 
The Extracellular Matrix of the TM. 
  The ECM of the TM is a complex, yet highly organized, scaffold of 
glycosaminoglycan’s (GAGs), proteoglycans, basement membrane proteins (collagen, 
laminin, fibronectin), matricellular proteins, and cell-surface ECM receptors.14 GAGs are 
negatively charged mucopolysaccharides primarily found bound to ECM that can be 
divided into 4 subclasses: heparan sulfate, chondroitin sulfate, keratan sulfate, and 
hyaluronic acid.33 The role of GAGs in the pathogenesis of POAG is still emerging, but 
evidence suggests they may play a role in regulating AH outflow resistance through the 
TM.34 Collagens type I, III, IV, and VI are expressed in the TM and form evenly-spaced 
fibrils that are essential for providing support for cell attachments and tensile strength to 
the TM. Type VI collagens, in particular, have been observed to be a key component of 
fibrils attaching cells of SC to the JCT. 35-37 Non-fibrillar collagens (type VII, VIII, XI, 
XV, and XXII) are also expressed by the TM, though their specific function is not well 
understood. The TM also contains extensive microfibril networks, often referred to as 
sheath-derived plaques, composed of elastin, fibronectin, versican, fibrillin, and 
decorin.16, 38, 39 These microfibrils are known to bind to numerous cell surface receptors. 
The TM also expresses a number of cell-surface receptors enabling attachment of ECM 
to TM cells including integrins, syndecans, and CD44.13, 14 The role of these receptors in 
IOP regulation is unclear, but may involve the formation of cross-linked actin networks 
(CLANs) and binding of cells to fibronectin containing microfibrils.40, 41 
  Degradation and biosynthesis of new ECM components are essential to normal 
TM maintenance. In order to tightly regulate ECM turnover, the TM expresses and 
regulates a variety of proteinases. MMPs,  plasminogen activator (PA), tissue inhibitors 
9 
of metalloproteinases (TIMPS), and PA inhibitor (PAIs) have all been localized to the 
TM.42, 43 MMPs are a family of calcium-dependent endopeptidases that degrade 
collagens, fibronectin, decorin, versican and elastin.44, 45 Whereas MMP-2, -14, -15, and -
16 are constitutively expressed by the TM,43, 46 MMP-1, -3, and -9 are inducible and 
upregulated in response to various cytokines or growth factors.47 PAs have also been 
demonstrated to activate proMMPs, while PAIs inhibit MMP activity.48 Addition of 
purified MMPs to perfused human anterior segments elicits marked increases in outflow 
facility while the addition of TIMPs significantly decrease outflow facility.49 These data 
strongly suggest that MMPs are constitutively active within the TM and that MMP 
activity modulates AH outflow through the TM. MMPs may contribute to IOP 
maintenance by a mechanism involving more than simple ECM degradation, as they are 
also involved in cell-matrix interactions, activating latent proteins, and providing clues 
for cell proliferation and survival.44 Altered ECM composition or increased ECM content 
may elicit aberrant elevation of IOP by increasing cell-protein interactions and ECM 
cross-linking. This in turn would increase TM rigidity and interfere with the TM’s ability 
to sense changes in pressure and adjust ECM turnover.  
  Patients with POAG display a characteristic accumulation of ECM components in 
the TM. Post mortem studies have demonstrated increased expression of fibrillin-1 and 
collagen VI containing sheath-derived plaques in JCT region of the TM when compared 
to age-matched healthy controls.16, 50 While the full composition and function of these 
plaques remains unclear, it is likely that these plaques do play an integral role in the 
aberrant increase in AH outflow resistance. The TM of glaucomatous patients is also 
stiffer than healthy individuals when measured by atomic force microscopy.51 
10 
Interestingly, increased tissue stiffness has also been linked to reduced pore formation in 
SC.52  
  There are also marked differences in the gene expression profiles of various ECM 
components between glaucomatous and healthy eyes. Liton et al. found marked increases 
in the expression of fibronectin, collagen (types III, V, VI, XI, and XIV), laminin, and 
thrombospondin-3 mRNA in glaucomatous TM cells, compared to TM cells harvested 
from healthy eyes.53 In this same study, integrinα9, MMP3, and MMP10 were 
significantly decreased. Diskin et al. demonstrated marked increases in the levels of 
syndecan 4, intercellular adhesion molecule (ICAM)-1 and several other ECM 
components in post-mortem glaucomatous tissue.54 While its mechanism is not yet fully 
understood, it is likely that ECM accumulation or remodeling plays a causal role in IOP 
elevation in patients with POAG. Consequently, manipulation of ECM turnover remains 
an important area of interest for the development of new therapeutic strategies. 
 
Transforming Growth Factor-β2 and POAG. 
  We and others have shown that AH collected from some POAG patients prior to 
phacoemulsification contains aberrantly elevated levels of the pro-fibrotic cytokine 
transforming growth factor (TGF)-β2.55-59 Perfusing biologically active TGF-β2 (10 
ng/ml) through human or porcine anterior segments elicits a marked and sustained 
decrease in outflow facility.60-63 Similarly, adenoviral gene transfer of TGF-β2 into 
rodent eyes in vivo significantly increases IOP within days of injection.64, 65 Collectively, 
these data suggest a causative role for biologically active TGF-β2 in the pathogenesis of 
POAG.  
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  TGF-β2 is a member of the TGF-β superfamily involved in the regulation of 
proliferation, differentiation, embryonic development, and wound healing.66 Early studies 
report expression and localization of all three isoforms of TGF-β in multiple ocular 
tissues including the lens epithelial cells, conjunctival stroma, and the ciliary body.67, 68 
The TM is no exception, and in vitro studies by our laboratory clearly demonstrate 
constitutive expression and secretion of TGF-β2 from cultured primary and transformed 
human TM cells.60, 69, 70 Interestingly, all three TGF-β isoforms are remarkably similar, 
sharing over 80% sequence homology and activating the same signaling pathways.71 
Only TGF-β2, however, has been shown to be elevated in the AH of affected patients,  
and consequently, considered relevant to the pathogenesis of POAG. TGF-β2 is secreted 
as an inactive latent propeptide, bound to one of four latent TGF-β binding proteins.66, 72 
Following proteolytic processing by either thrombospondin-1 or plasmin mediated 
cleavage; a homodimer of the now biologically active TGF-β2 binds to a subtype of the 
transforming growth factor receptor (TβR) subfamily, TBRII (Figure 4). Activated, 
ligand-bound, TβRII monomers then dimerize to enable recruitment and 
transphosphorylation of a distinctly separate (type I; TβRI) subtype of the TGF-β 
receptor. A third TGF-β receptor (TβRIII) has been reported, but evidence suggests that 
this receptor serves as a non-essential accessory role at presenting TGF-β2 to TβRII.68 
Following transphosphorylation, TβRI undergoes a conformational change which elicits 
recruitment, and phosphorylation, of canonical receptor-associated smad signaling 
proteins (R-smad2 and R-smad3).73  
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Dimers of phosphorylated R-smad2 or R-smad3 passively associate with a third un-
phosphorylated smad protein (smad4). The newly formed smad heterotrimer enters the 
nucleus by an unknown mechanism where it initiates transcriptional events by 
complexing with smad binding elements (SBEs) present within the genome. In addition 
to this well-characterized canonical signaling pathway, TGF-β2 also activates several 
signaling pathways that are independent of the smad proteins, including the mitogen-
activated protein (MAP) kinase, phosphoinositide (PI)-3 kinase/activated protein kinase 
(AKT), c-jun n-terminal (JNK), and Rho GTPase/Rho kinase pathways.74, 75  Cross-talk 
between these non-canonical pathways and smad proteins are essential for downstream 
regulation and modulation of TGF-β mediated signaling.60 
  TGF-β2 activated signaling pathways play a vital role in the regulation of cell 
proliferation, inflammation, and ECM production. As ECM dysregulation is critical 
Figure 4. Canonical TGF-β2 Signaling: Diagram of the 
canonical, R-smad mediated signaling pathway. 
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component of POAG, it is plausible that elevated levels of TGF-β2 in AH of POAG 
patients induces increased ECM production/remodeling contributing to aberrant increases 
in AH outflow resistance. In vitro studies have established pro-fibrotic TGF-β2 as a key 
mediator of ECM protein expression and regulation in human TM cell, including 
collagens (I, III, IV, and VI), laminin, fibronectin, secreted protein acidic and cysteine 
rich (SPARC), PAI-1, and TIMP-1.47, 76, 77 TGF-β2 has also been shown to increase 
expression of ECM cross-linking genes transglutaminase-2 and lysyl oxidase, two 
enzymes which contribute to TM tissue stiffness.78 Experimentally altering TM elasticity, 
in vitro, modulates TGF-β2 mediated signaling and thereby promotes a phenotype similar 
to that of glaucomatous TM.79  Ex vivo, TGF-β2 promotes the accumulation of fibrillary 
matter and fibronectin in perfused anterior segments.62 Collectively, these studies suggest 
that the profibrotic cytokine TGF-β2 is an important initiator of fibrosis within the TM, 
eliciting increased resistance to AH drainage and elevated IOP. 
  While much is known about TGF-β signaling in the eye, our current knowledge of 
the mechanisms involved in the aberrant elevation of TGF-β2 in patient AH remains 
limited. Recent evidence suggests TGF-β2 expression levels within the TM may be 
influenced, in part, by epigenetic dysregulation. Overexpression of miR-29b, a micro 
RNA important in the regulation of DNA methyltransferases and histone deacetylase 
(HDAC)s, markedly decreases TGF-β2 mRNA content.70 The amount of secreted 
biologically active TGF-β2 is, however, unaltered by miR-29b. By comparison, 
hyperacetylation of histones associated with the TGF-β2 promoter markedly increases 
TGF-β2 expression in human TM cells.80 Additionally, perfusion of bovine anterior 
segments with a histone deacetylase inhibitor concomitantly increases TGF-β2 
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expression and decreased outflow facility.80 Alternatively, inhibition of Rho GTPases 
decreases constitutive synthesis and secretion of TGF-β2 from TM cells.60 Therefore it is 
likely that both increased RhoA activity, as well histone hyperacetylation, play an 
important role in the pathogenesis of POAG by increasing TGF-β2 expression and release 
by the TM.60 
 
Non-Canonical Rho GTPase Signaling in POAG. 
Included among the Ras superfamily of small monomeric GTPases is a family of 
Rho GTPases (Rho, Rac1, Cdc42) that regulate a diverse array of intracellular signaling 
pathways which affect vesicle transport/trafficking, endocytosis, cell cycle progression, 
cell contractility, stress fiber or focal adhesion formation.81-83 Of these, the Rho 
subfamily consists of RhoA, RhoB, and RhoC. Following activation by guanine 
nucleotide factor-mediated GDP: GTP nucleotide exchange, GTP-bound Rho activates 
Rho-associated protein kinases (ROCK1 & ROCK2). Once activated, these kinases 
phosphorylate and activate LIM kinase which in turn stabilizes filamentous actin 
networks by inactivating cofilin, an actin depolymerase (Figure 5).84, 85 
  In parallel, activated Rho kinases also phosphorylates myosin light chain (MLC) 
while inhibiting MLC phosphatase, indirectly facilitating contraction of polymerized 
actin fibers. Studies from our laboratory have shown that in human TM cells, TGF-β2 
mediated activation of Rho GTPase signaling elevates IOP, in part, by modifying F-actin 
stress fiber organization and promoting cell contractility.83, 86, 87TGF-β2 treated TM cells 
have also been reported to exhibit a modest increase in Rac1-mediated formation of 
cross-linked actin networks, which may contribute to elevated IOP.88 Interestingly, 
15 
expression of constitutively active RhoA significantly increases expression of fibronectin, 
tenascin, laminin, and alpha-smooth muscle actin.89 
 
 In vivo, constitutively active RhoA induces elevated IOP and an associated 
increase in F-actin, both of which are ameliorated by Rho kinase inhibitors.90 Perfusion 
of porcine anterior segments with the ROCK inhibitor Y-27632 decreases outflow 
resistance in a dose dependent manner.91 In vivo, topical administration of ROCK 
inhibitors to both normotensive and ocular hypertensive rabbits results in a significant 
decrease in IOP, further solidifying the link between TGF-β2 mediated increases in Rho 
GTPase activity and the pathophysiology of POAG.92 
 
Endothelin-1 Mediated Vasoconstriction in POAG. 
  Endothelin-1 (ET-1) is a potent vasoactive peptide that is also elevated in the AH 
of patients with POAG.93-96  In this regard, our laboratory observed a modest increase in 
ET-1 content in AH samples from Veterans with POAG (40 ± 20 fg/µl; n = 6) as 
Figure 5. Rho mediated signaling. Diagram of the Rho GTPase 
mediated signaling pathway adapted from Cellular Biochemistry 
II. 
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compared to healthy age-matched subjects (20 ± 10 fg/µl; n= 10). POAG patients with 
progressive visual loss have elevated plasma levels of ET-1 compared to POAG patients 
with stable visual function.97 Plasma levels of ET-1 in patients with NTG are similarly 
increased, compared to healthy age-matched controls, indicating that this peptide may 
also be involved in the pathogenesis of NTG.98  
  Of the three endothelin isoforms (ET-1, ET-2, ET-3) reported, only ppET-1 is 
thought to modulate outflow facility by binding to one of two major metabotropic G-
protein coupled receptor subtypes (ETA or ETB) expressed within TM. Secreted as a 
prepropeptide from human TM cells,99 ppET-1 undergoes proteolytic processing to its 
mature 21 amino acid ET-1 form by endothelin converting enzymes (ECE). While ET-1 
is best known as a vasoactive peptide responsible for controlling vascular tone, it also 
stimulates cell migration, ECM deposition, and the secretion of inflammatory mediators 
and growth factors. Activation of ETA receptors elicits pronounced vasoconstriction by 
stimulating phospholipase Cβ, liberating inositol 1,4,5-trisphosphate from 
phosphatidylinositol 4,5-bisphosphate, mobilizing intracellular calcium, and ultimately 
eliciting a marked contraction of the actin cytoskeleton. ETA also stimulates the activation 
of small monomeric Rac1 and RhoA GTPases.100, 101 In contrast, activation of ETB 
receptors facilitates vasodilation by eliciting nuclear factor-κB (NF-kB)-mediated 
synthesis and release of cyclins and nitric oxide.102 Activation of ETB receptors is also 
reported to promote retinal ganglion cell death in POAG.103, 104 An additional receptor 
subtype (ETC) has been identified, although its physiological significance is uncertain.  
 The corneal epithelium, iris, ciliary body, choroid, retinal vessels, and optic 
nerves constitutively express and release ET-1.105, 106 While quiescent TM cells do not 
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express measurable levels of ET-1, challenging cultured primary human TM cells with 
TGF-β2 robustly increases both the synthesis and secretion of ET-1.99, 107 Both ETA and 
ETB receptors are constitutively expressed by human TM cells,108, 109 and treatment with 
exogenous ET-1 induces RhoA GTPase dependent contraction of the actin cytoskeleton, 
supporting a physiologic role for ET-1 in the TM.110 ET-1 is also pro-fibrotic mediator, 
known to induce accumulation of collagens type I and VI in optic nerve head 
astrocytes.111 Administration of ET-1 ex vivo acutely increases outflow resistance in 
perfused bovine anterior segments, possibly by remodeling the ECM.112 Interestingly, 
intravitreal injection of ET-1 produces a rapid, but transient, increase in IOP in rabbits 
that can be inhibited by selective ETA receptor antagonist.113. It remains quite plausible 
that elevated content of TGF-β2 in AH of affected patients elevates IOP by a mechanism 
involving ET-1 mediated contraction of the actin cytoskeleton and remodeling of the 
ECM in the TM. 
 
Connective Tissue Growth Factor Mediates TGF-β2 Remodeling of the ECM. 
  Connective tissue growth factor (CTGF) is a secreted, multi-modular member of 
the CCN (CTGF, Cyr61, Nov) family of regulatory proteins essential in the regulation of 
angiogenesis, wound healing, and fibrosis. 114-116 The many diverse biological functions 
of CTGF are mediated by its four unique domains: insulin-like growth factor binding 
(IGFB) domain, chordin-like cysteine-rich domain, thrombospondin type-1 repeat 
domain, and a C-terminal cysteine-knot.9, 117 CTGF expression is primarily regulated at 
the transcriptional level and is induced by hypoxia, mechanical deformation, sheer stress, 
and various growth factors.118, 119  
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  Whereas CTGF is one of the most highly expressed genes in the TM,9 others have 
found TGF-β2 markedly increases CTGF expression in primary and transformed human 
TM cells. 120, 121 ET-1 has also been shown to increase CTGF expression in fibroblasts122 
although this finding has not been repeated in TM cells. While a specific CTGF receptor 
has not been reported, CTGF itself binds with integrins, tyrosine kinase receptors, and 
epidermal growth factor receptors. These findings suggest that CTGF acts a molecular 
bridge, integrating extracellular proteins and intracellular signaling networks. Regions 
within the cysteine-rich domain of CTGF interact with TGF-β to prolong TGF-β 
mediated signaling.123  
  Several in vitro studies have now shown that CTGF serves as a critical 
downstream mediator of pro-fibrotic TGF-β2 signaling.121, 124 In CTGF null embryonic 
fibroblast, TGF-β2 elicits potent smad3 phosphorylation but fails to increase expression 
of α-smooth muscle actin.125 In TM cells, siRNA mediated knockdown of CTGF prevents 
TGF-β2 mediated increases in fibronectin, and actin stress fiber formation.120 
Alternatively, CTGF can mimic many of the molecular mechanisms and structural 
aspects of POAG seemingly independent of TGF-β2 signaling. In vivo, adenoviral 
overexpression of CTGF in the anterior chamber produces a glaucomatous phenotype, 
with mice displaying increased fibronectin expression in the TM, elevated IOP, and optic 
nerve damage.120, 121 In vitro, addition of CTGF to human TM cell cultures induces 
increased actin stress fiber formation as well as deposition of fibronectin and collagens I, 
II, IV, and VI.126 CTGF has no effect, however, on the activity of MMP-2, MMP-9, or 
PA-1. In contrast, TGF-β2 markedly enhances PA-1 activity in human TM cells. Thus, 
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while TGF-β2 and CTGF tend to elicit similar effects, these results show that each can 
induce distinct and independent outcomes from one another.120  
  While patients with pseudoexfoliation (PFX) glaucoma, a secondary form of 
glaucoma caused by increased deposition of white, dandruff-like material in the anterior 
segment, do exhibit an elevated content of CTGF in their AH, patients with POAG were 
found to have levels similar to those of age-matched healthy controls.127 While it is 
premature to implicate CTGF as causative in the pathogenesis of POAG, an association 
between TGF-β2 and CTGF appears likely as a critical mediator of fibrosis in the TM of 
patients with POAG. In separate studies examining systemic sclerosis, TGF-β injections 
into the dermis of mice resulted in only a transient dermal fibrosis. TGF-β injections 
followed by serial injections of CTGF, however, led to a sustained fibrotic phenotype.128 
We propose that elevated levels of TGF-β2 in the AH of patients with POAG initiates 
remodeling of ECM that is subsequently sustained, or perhaps exacerbated, through the 
actions of CTGF. 
 
TGF-β2 Mediated Perturbation of the Kallikrein-Kinin System in POAG. 
  An equally engaging mechanism by which TGF-β2 may promote pathological 
elevation of IOP includes perturbation of the Kallikrein-Kinin system. Early studies 
reported that bradykinin (BK), a potent vasodilating kinin peptide, was capable of 
lowering IOP. Perfusion of bovine or human anterior segments with bradykinin elicited a 
marked, but transient, decrease in IOP.129, 130 Intravitreal injection of BK induced a 
significant and sustained (~8h) decrease in IOP in ocular hypertensive Dutch-belted 
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rabbits.130  Topically applied bradykinin, however, was without effect on IOP in either 
Dutch-belted rabbits or cynomolgus monkeys, 131 possibly due to cornea restricted 
bioavailability. By comparison, topical application of FR-190997, a hydrophobic 
bradykinin analog, reduced IOP in ocular hypertensive monkeys.29, 132 Collectively, these 
data support the use of BK analogues as novel, potentially viable, regulators of AH 
outflow. Their development and application as a first-line therapeutic strategy for the 
management of POAG, however, awaits clinical phase trial evaluation and refinement.  
The kallikrein-kinin system (Figure 6) consists of specific serine proteases 
(kallikreins) that act upon kinin peptide precursor proteins (kininogens) to generate 
biologically active nonapeptide bradykinin (H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-
OH) and decapeptide kallidin.133, 134 Kallidin can subsequently be cleaved by 
aminopeptidases to form bradykinin.135 Importantly, the biochemical machinery 
responsible for synthesizing bradykinin has been detected in trace amounts in AH from 
human and porcine.136, 137 Kallikreins and kininogens have also been localized to the 
human retina, choroid, ciliary body, optic nerve, and TM.130, 138 
Figure 6. The Kallikrein-kinin System. Diagram of the 
components of the kallikrein-kinin system adapted from 
Heitsch 2000.4 
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Intracellular signaling events initiated by the kinins are governed by two selective 
subtypes of metabotropic G-protein coupled receptors (B1 and B2). The B1 receptor is an 
inducible receptor and is typically expressed only in response to a traumatic or 
inflammatory challenge.139 Although B1 receptor mRNA has been localized to ocular 
tissues, this receptor has not been detected at the protein level within the eye.130 
Moreover, B1 receptor agonists, including Des-Arg9-BK (an active metabolite of BK), 
fail to elicit any measurable responses, in vitro, from TM, ciliary body, or non-pigmented 
epithelial cells.130, 131 By comparison, the B2 receptor is constitutively expressed in a 
variety of tissues including brain stem, cerebral cortex, thalamus, and the ependyma of 
the lateral and third ventricle.133 In the eye, the B2 receptor is expressed in the TM, 
ciliary muscle, nonpigmented epithelium, optic nerve, and retina.130, 131, 140 
Given its constitutive expression and localization within the eye, activation of the B2 
receptor, rather than the B1 receptor, is believed to largely mediate kinin-dependent 
ocular hypotension. Perfusing anterior segments with HOE-140, a B2 receptor antagonist, 
prevents bradykinin dependent lowering of IOP.129, 140 Furthermore, bradykinin exhibits a 
much higher (>1000 fold) affinity for the B2 receptor compared to the B1 receptor.133 
Bradykinin, however, is an extremely labile peptide (half-life in plasma of 15s).141 Both 
bradykinin and kallidin are quickly metabolized by kininases that include 
carboxypeptidases, aminopeptidases, angiotensin converting enzymes, and neutral 
endopeptidases. While the use of kininase inhibitors to extend the therapeutic effect of 
bradykinin seems logical, this avenue may produce limited results as the B2 receptor also 
exhibits rapid agonist-dependent desensitization.142 The effect of long-term repeated 
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exposure to bradykinin on B2 receptor localization and function in the eye remains 
unknown. 
  While the B2 receptor is typically coupled to G-protein effector Gαq, this receptor 
also couples with Gαi, Gαs, and Gα12/13.143-145 Binding of bradykinin to the B2 receptor 
stimulates Gαq mediated activation of phospholipase Cβ, thereby catalyzing the 
breakdown of phosphoinositol-4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate 
(IP3) and diacylglycerol (DAG).146 IP3 subsequently binds to and opens a calcium-
selective ligand-gated ion channel expressed on a subdomain of the endoplasmic 
reticulum, resulting in the mobilization of intracellular calcium. Cultured TM cells 
exposed to bradykinin exhibit a rapid (40s) increase in intracellular calcium, which 
subsequently activates a plethora of calcium-dependent enzymatic pathways, including 
phospholipase (PL) A2.147, 148 Cyclooxygenases expressed in TM cells metabolize PLA2-
catalyzed release of arachidonic acid to prostaglandins and thromboxanes. Ciliary muscle 
cells, non-pigmented ciliary epithelial cells, and cells of the TM respond rather robustly 
to bradykinin by increasing prostaglandin secretion.130, 131 The ocular hypotensive effects 
of bradykinin can thus be attributed, at least in part, to local stimulation of prostaglandin 
secretion from the ciliary body leading to increased uveoscleral outflow. Perfusing human 
anterior segments with a prostaglandin F2α analog (Latanoprost) also lowers IOP 
(increases outflow facility), suggesting that increased production of prostaglandins by the 
TM may also act locally to increase AH outflow through the conventional pathway.149 
This possibility, however, remains contentious. An alternative mechanism by which BK 
may influence conventional outflow involves production of MMPs, including MMP-9. In 
vitro BK induces a rapid but transient phosphorylation of the MAP kinase cascade 
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leading to increased MMP-9 secretion.140, 150 Inhibition of this proteinase prevents 
bradykinin mediated changes in outflow facility in bovine anterior segment perfusion 
studies.129 These results suggest that bradykinin may elicit matrix metalloproteinases 
mediated ECM turnover within the TM. We are unaware of any studies to date, however, 
that have demonstrated bradykinin mediated changes in ECM content within the TM.130  
  The use of bradykinin as a potential therapeutic warrants further examination. 
However, it is worth noting that no previous study has accounted for how elevated levels 
of TGF-β2 in patient AH may affect bradykinin mediated signaling. Airway smooth 
muscle cells respond to a TGF-β2 challenge in a dose- and time-dependent manner by 
increasing B2 receptor mRNA and receptor protein content leading to a potentiation of 
bradykinin mediated increases in intracellular calcium.151 In marked contrast, we have 
recently demonstrated that TGF-β2 markedly decreases B2 receptor mRNA content in 
human TM cells within 24h.152 While changes in mRNA levels do not always correspond 
to protein content, or even the functional state of the receptor, further studies are 
warranted to determine the effect TGF-β2 on the kallikrein-kinin system within the TM.  
 
Mechanosensation within the TM. 
  IOP is not static, but rather dynamic, constantly fluctuating due to blinking, eye 
movement, or oscillations associated with ocular pulse. Within the TM, there exist 
regulatory mechanisms designed to maintain IOP at a healthy level. Anterior segment 
perfusion studies demonstrate that a rapid rise in IOP elicits compensatory changes in 
outflow resistance that quickly return IOP to near baseline pressures, demonstrating the 
TM’s ability to dynamically respond to and regulate IOP homeostasis.19, 153, 154 The 
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hydraulic conductivity of AH through the TM is primarily determined by TM cell 
contractility and extracellular environment.14, 155 Consequently, the homeostatic response 
of the TM to an increased pressure load must ultimately include compensatory alterations 
in ECM turnover and modification of the cytoskeleton leading to a collective decrease 
AH outflow resistance. The effect of chronic over activation of this response by sustained 
elevated IOP is not well understood, but most likely leads to a permanent remodeling of 
the ECM and change in cell morphology.  
  Elevated IOP is most often modelled in vitro, by the culture of TM cells on a 
flexible membrane followed by uni- or biaxial stretch resulting in distortion of the plasma 
membrane. In studies utilizing cultured human and bovine TM cells, application of either 
cyclical or static stretch increases the expression and secretion of active MMP-2.156, 157 
By comparison, the effect of stretch on the expression of  TIMPs is unclear. Cyclical 
stretch of bovine TM cells results in increased TIMP-1 expression, while static stretch 
has no effect upon the levels either of TIMP-1 or TIMP-2.158 This lack of consistency 
highlights the importance of utilizing multiple systems to model the mechanical stress 
experienced by the TM. To date, three independent studies have examined changes in the 
gene expression profile in response to mechanical stress, each utilizing a distinct model. 
Gonzalez et al. investigated the effects of high perfusion pressure (50 mmHg x 6h) on 
TM cells in perfused human anterior segments.159 In this study, eleven genes involved in 
ECM remodeling, cytoskeleton reorganization, and reactive oxygen species (ROS) were 
consistently upregulated.159 Vittitow and Boras identified 40 upregulated and 14 
downregulated genes in response high perfusion rate (10 µl/min) over 2-4 days in 
perfused human anterior segments.160 Interestingly, MMP-2 expression was significantly 
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increased in this model, similar to in vitro studies. Finally, Vittal et al. characterized the 
effect of static stretch (up to 48h) in porcine TM cells.46 In this assay, 126 genes were 
upregulated including CTGF, fibronectin, and collagen XIV. Cyclical stretch of human 
TM cells in vitro has also been demonstrated to increase TGF-β1, CTGF, and MMP-2 
content.161 These changes in gene expression were prevented by the addition of a TGF-β1 
neutralizing antibody. While TGF-β1 content was increased in this experiment, the effect 
of cyclical stretch on TGF-β2 was not determined. In addition to inducing changes in 
gene expression, mechanical stress may lead to alternative mRNA splicing. Mechanical 
stretch of porcine TM cells induces both increased content and a novel isoform with 
deletion of two exons and a premature stop codon, of collagen XII mRNA.162 Changes 
such as these could very likely affect ECM stiffness or ECM-cell interactions interfering 
with healthy IOP homeostasis. 
  The mechanisms by which TM cells sense and respond to mechanical stretch have 
yet to be elucidated, but may involve the mechanosensitive receptor transient receptor 
potential vanilloid (TRPV) 4.163 TRPV4 is a nonselective cation channel that is activated 
by a disparate variety of stimuli including hypotonicity, mechanical deformation, heat, 
and pH.164 TRPV4 is constitutively expressed in vivo in mouse and human TM tissues as 
well as endothelial cells of SC and non-pigmented epithelial cells.165, 166 Pharmacological 
activation of TRPV4 in vitro increases fibronectin secretion and induces a marked 
increase in intracellular calcium in both primary and immortalized TM cells.165 
Furthermore, the formation of actin stress fibers and focal adhesion complexes induced 
by mechanical stretch of TM cells is completely abrogated by the TRPV4 inhibitor HC-
06.165 Interestingly, inhibition of TRPV4 in human bronchial cells prevents Rho GTPase-
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mediated ATP release induced by hypotonicity implying that TRPV 4 may regulate the 
activity of this small monomeric G-protein.167 The role of TRPV4 in the regulation Rho 
GTPase activity in the TM, however, remains unknown. When the TRPV4 antagonist 
HC-06 was administered intraperitoneally in the mouse microbead occlusion model of 
POAG, however, inhibition of TRPV4 concomitantly decreased IOP and enhanced RGC 
survival.165 Collectively, these results strongly suggest that TRPV4 is a critical mediator 
of mechanosensation within the TM. Moreover, elevated IOP may chronically over 
activate TRPV4 channels, leading to a permanent increase in fibronectin deposition, 
RhoA GTPase activation, actin stress fiber formation, and retinal ganglion cell death. 
  Of the various types of mechanical stimuli experienced by the TM, increased 
hydrostatic pressure is the least often studied form and consequently the least well 
understood. Hydrostatic pressure is unique in that it is a non-deforming, isotropic mode 
of stress. Consider that mammalian cells are essentially fluid filled “sacs” that exhibit 
very little compressibility. An increase in 10 MPA (75,006 mmHg, upper range of 
hydrostatic pressure experienced in vivo) would result in only a 0.4% change in cell 
volume.169, 170 Thus the mechanism by which cells sense elevated hydrostatic pressure 
and downstream signaling cascades coupled to this stimuli are most likely quite distinct 
when compared to other mechanical stressors (fluid sheer stress, physical stretch). 
Mechanical distension through biaxial stretch therefore, is most likely not a suitable in 
vitro model to mimic elevated hydrostatic pressure. 
  A more appropriate method to study the effects of elevated hydrostatic pressure 
involves injection of gas (95% air/5% CO2) into a sealed, humidified, and temperature 
controlled chamber with appropriate equipment to monitor and maintain pressure. 
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Numerous studies have utilized this model in a variety of cell types to examine the effect 
of elevated hydrostatic pressure on ocular tissues. Exposure of optic nerve head 
astrocytes identified 744 differentially expressed genes in response to elevated 
hydrostatic pressure (60 mmHg) over time.171, 172 Interestingly, among the most 
responsive genes were Rho specific guanine nucleotide exchange factors, inducible nitric 
oxide synthase, and R-smad3.173 Additionally, elevated hydrostatic pressure (70 mmHg x 
24h) inhibits secretion of interleukin (IL)-6 from rat retinal astrocytes.174 In rat retinal 
microglia, however, IL-6 secretion is markedly enhanced in response to elevated 
hydrostatic pressure demonstrating that responses to changes in hydrostatic pressure are 
cell type specific. Human TM cells respond to elevated hydrostatic pressure by 
concomitantly increasing adenylyl cyclase activity and altering their actin 
cytoskeleton.175, 176 The effect of elevated hydrostatic pressure on TM cell gene 
expression and ECM turnover however, has yet to be elucidated.   
  Multiple studies have demonstrated that mitochondrial dysfunction and oxidative 
stress are early mediators of elevated hydrostatic pressure. When exposed to elevated 
hydrostatic pressure (60 or 100 mmHg), transformed RGC-5 cells increase expression of 
the antioxidant heme oxidase (HO)-1 in a dose dependent manner.177 Short-term exposure 
of RGC-5 cells to elevated hydrostatic pressure (100 mmHg) increases intracellular 
calcium followed by activation of caspase 3, leading to apoptosis.178 Similarly, culturing 
PC-12 cells (70 mmHg x 24h), glaucomatous TM cells (80 mmHg x 24h), or RGC-5 cells 
(30 mmHg x 72h) elicits a marked decrease in cellular ATP and a collapse of 
mitochondrial membrane potential while inducing apoptosis.179-181 Elevated hydrostatic 
28 
pressure most likely induces apoptosis through abnormal mitochondrial fission initiating 
increased release of optic atrophy type I (OPA1) and cytochrome c into the cytoplasm.182  
 In vitro studies demonstrating increased oxidative stress in response to elevated 
hydrostatic pressure parallel observations of oxidative damage found in glaucomatous 
eyes. Early reports found increased content of endothelial leukocyte adhesion molecule-1, 
a known cellular response to oxidative stress, in glaucomatous TM.183 More recently, an 
increase in end-product lipid peroxidation was found in patient SC and TM when 
compared to healthy controls.184 A separate study demonstrated increased oxidative DNA 
damage that positively correlated with increased IOP and visual field loss.185 
Glaucomatous TM also exhibit increased deletion of mitochondrial DNA, indicative of 
mitochondrial failure.186 Finally, AH from glaucomatous patients contains increased 
levels of malondialdehyde (a marker of oxidative stress) and enzymatic antioxidants, 
super oxide dismutase and glutathione peroxidase.187, 188 The levels of malondialdehyde 
in patient AH also correlated positively with severe visual loss. It is clear that patients 
with POAG experience increased oxidative stress, most likely as a result of elevated IOP. 
However, the effect of increased oxidative stress on the conventional outflow pathway 
has yet to be elucidated. Due to diminished antioxidant defenses, the TM is highly 
sensitive to ROS. Thus, the TM may be uniquely susceptible to oxidative damage.189 In 
this regard, short-term (30 min) oxidative insult has been demonstrated to reduce cell 
binding to ECM components fibronectin collagen (types I and 4) and laminin leading to a 
reversible rearrangement of the actin cytoskeleton.190 Application of chronic oxidative 
insult inhibits the proteasome, promotes TM senescence, and reduces TM cell viability.191 
Of particular relevance, TGF-β stimulates ROS production while simultaneously 
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decreasing antioxidant expression in various tissues. 192, 193 Elevated content of TGF-β2 
in the AH therefore may very well contribute to the pathogenesis of POAG by increasing 
ROS in the TM. Further studies are currently being conducted by this laboratory to 
specifically determine the effect of elevated hydrostatic pressure and TGF-β2 on 
oxidative stress in the TM. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
Human Trabecular Meshwork Cell Culture. 
 The use of human cadaver material by this laboratory is approved by the Edward 
Hines Jr. VA and Loyola University Chicago institutional review boards in compliance 
with the tenets of the Declaration of Helsinki Fresh cadaver corneoscleral rims from 
healthy individuals were obtained (Eversight Illinois, Chicago, IL) at the time of corneal 
transplant and primary human TM cells are prepared using a collagenase-free procedure 
as described previously.60, 83, 86, 87, 99 Briefly, TM cells were cultured on Falcon Primaria 
flasks in Eagle’s Minimum Essential Medium containing 2 mM L-glutamine 
supplemented with 5% adult bovine serum, 10% fetal bovine serum, 0.1% gentamycin, 
1% amphotericin B, and a mixture of essential and non-essential amino acids. The purity 
of primary human TM cell cultures typically exceeds 95%, as routinely determined by 
cell morphology (adherent flattened non-spindle shaped soma with prominent 
lamellipodia). Currently, there are no known cytochemical markers of TM cells. TM cell 
viability is typically >90% as determined by trypan blue (0.2%) dye exclusion. Primary 
TM cell cultures exhibiting more than 5% spindle-shaped morphologic characteristics are 
considered contaminated with fibroblasts and discarded. Individual TM cell lines were 
restricted to a maximum of 6 passages. Simian virus 40-transformed human TM cells 
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from a healthy donor (NTM5) and a glaucomatous donor (GTM3) were acquired from 
Alcon Laboratories (Fort Worth, TX) and were cultured in Dulbecco's Modified Eagle's 
Medium (DMEM) containing 4 mM GlutaMAX-I supplemented with 10% fetal bovine 
serum, 100 U/ml penicillin, and 100 µg/ml streptomycin, and 1% amphotericin B. TM 
cultures were maintained at 37°C under an atmosphere of 95% air/5% CO2. 
 
Experimental Conditions. 
  Upon reaching confluence, cells were cultured x 24h in fresh serum-free DMEM 
media supplemented with 100 U/ml penicillin, and 100 µg/ml streptomycin, and 1% 
amphotericin B, and subsequently challenged with TGF-β2 (Cell signaling: 1-5 ng/ml) 
for up to 48h. In some experiments, cells were pretreated with C3 exoenzyme 
(Cytoskeleton, 10 µg/ml) or with actinomyocin D (Sigma-Aldrich, 1 µg/ml) x 30 min as 
indicated. To determine the effect elevated hydrostatic pressure elicits on gene expression 
in TM cells, confluent serum-starved TM cells were placed in a custom made humidified 
chamber (Figure 7A) pre-warmed to, and maintained at, 37°C  and pre-charged with an 
atmospheric mixture of 95% air/5% CO2. Once the chamber was sealed, the hydrostatic 
pressure within the chamber was elevated by allowing a small amount of additional 
compressed air mixture to enter the sealed chamber. To measure hydrostatic pressure in 
real-time, one end of communicating polyethylene tubing (0.034 x0.050 in) was fastened 
to an exposed (no lid), mid-level positioned, 100 mm petri dish containing an equivalent 
volume of sterile saline. The other end of the tubing was fastened to an internal stainless 
steel communicating port that traversed the chamber wall. An additional piece of 
polyethylene tubing (0.034 x 0.50 in) was fastened to the external end of the stainless 
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steel communicating port and the remaining open end attached to an APT300 pressure 
transducer (Harvard Apparatus). Hydrostatic pressure was continuously monitored in 
real-time and recorded (Figure 7B) every 30s with an available PowerLab 8/35 high-
performance data acquisition system supplied with LabChart Pro software. Cells were 
cultured at elevated hydrostatic pressures of 15, 30, or 45 mmHg above ambient (1 
atmosphere/760 mmHg) pressure x 1.5h, 3h, 6h, or 48h. For comparison, control cells 
were cultured in an identical manner in a tissue culture incubator at 37°C (ambient 
pressure) under a humidified atmosphere of 95% air/5% CO2. No significant change in 
media pH was observed between elevated and ambient controls. In some experiments, 
cells were pretreated with various receptor antagonists AMG-9810 (Sigma-Aldrich, 1 
µM), BQ-123 (Sigma-Aldrich, 1 µM), BQ-188 (Sigma-Aldrich, 1 µM), HC-06747 
(Sigma-Aldrich, 1 µM), or SB-431542 (Sigma-Aldrich, 1 µM) x 30 min as indicated. 
Alternatively, cells were pretreated with antioxidants trolox (Sigma-Aldrich, 100 µM) or 
resveratrol (Cayman Chemical, 20 µM) x 24h prior to treatment. Higher doses of 
resveratrol were noted to be toxic to GTM3 cells as indicated by MTT and LDH assays. 
 
 
 
 
 
 
 
 
Figure 7. Hydrostatic Pressure Chamber. (A) Custom built chamber used 
to expose culture cells to elevated hydrostatic pressure. (B) Representative 
sustainable pressure load on culture GTM3 cells as a function of time.  
B. A. 
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siRNA-Targeted Knockdown.  
 Semi-confluent cultures of human TM cells were transfected x 24h with 
commercially available silencer siRNA (Ambion/ThermoFisher Scientific) directed 
against R-Smad2 (25 nM), R-Smad3 (10nM), or a scrambled sequence (25 nM; negative 
control) using lipofectamine RNAiMAX reagent in a 1:1 mixture of Opti-MEM and 
DMEM lacking serum, antibiotics, and antimycotics. Alternatively, primary human TM 
cell cultures were reverse-transfected x 8h in the same manner. Following transfection, 
culture media was replaced with serum-free DMEM containing 100 U/ml penicillin, and 
100 µg/ml streptomycin, and 1% amphotericin B, and cells were incubated in the absence 
or presence of TGF-β2, as indicated. 
 
Real-Time RT-PCR.  
  Total RNA was extracted from human TM cells with TRIzol reagent and 1 µg 
was reverse-transcribed using iScript Reverse Transcription Supermix (BioRad) as 
previously described.99 Human specific oligonucleotide primers (Table 1) were amplified 
by real-time PCR using either a Mini-Opticon or CFX Connect Real-Time PCR detection 
system. For each sample, the specificity of the real-time reaction product was determined 
by melt curve analysis. Reaction efficiencies for each transcript were between 90 and 
110%. Relative fold-changes in mRNA expression were normalized to GAPDH. The 
expression profile of GTM3 cells exposed to hydrostatic pressure was measured using a 
predesigned “POAG” microplate array (Bio-Rad) according to the manufacturer’s 
instructions.  
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Gene Sequence Protocol Amplicon 
Size (bp) 
    
BK B1R 5’-ATCTGGTGTTTGTCTTGGCC-3’ 
3’-AGGCCAGGATGTGGTAGTTG-5’ 
 
94˚C x 5min, (94˚C x 60s, 62˚C x 45s, 
72˚C x 10s) x 35 
435 
BK B2R 5’-ACACAGGGCAGTCATTCAGCAC-3’ 
3’-CATGCATAGGGCCGCTCTTC-5’ 
95˚C x 5min, (95˚C x 30s, 60˚C x 60s, 
72˚C x 30s) x 30 
143 
   
Col1α1 5’-CTAAAGGCGAACCTGGTGAT-3’ 
3’-TCCAGGAGCACCAACATTAC-5’ 
95˚C x 5min, (95˚C x 30s, 60˚C x 45s, 
72˚C x 30s) x 40 
107 
   
Col1α2 5’-GAAGGAAAGAGAGGCCCTAATG-3’ 
3’-TCCAGGAAGACCACGAGAA-5’ 
95˚C x 5min, (95˚C x 30s, 60˚C x 45s, 
72˚C x 30s) x 40 
96 
    
Col2α1 5’-CAGGATGGGCAGAGGTATAATG-3’ 
3’-GAGGCAGTCTTTCACGTCTT-5’ 
95˚C x 5min, (95˚C x 30s, 60˚C x 45s, 
72˚C x 30s) x 40 
885 
    
Col4α1 5’-CGGGCCCTAAAGGAGATAAAG-3’ 
3’-GAACCTGGAAACCCAGGAAT-5’ 
95˚C x 5min, (95˚C x 30s, 60˚C x 45s, 
72˚C x 30s) x 40 
115 
    
Col6α1 5’-AAATGTGCTCTTGCTGTGAATG-3’ 
3’-GACGAAGTCCTTGGCAATCT-5’ 
95˚C x 5min, (95˚C x 30s, 60˚C x 45s, 
72˚C x 30s) x 40 
110 
    
CTGF 5’-CTCCTGCAGGCTAGAGAAGC-3’ 
3’-GATGCACTTTTTGCCCTTCTT-5’ 
94˚C x 5min, (94˚C x 10s, 60˚C x 40s) x 40 94 
    
ETA 5’ -GTTGAACAGAAGGAATGGCAGC- 3’ 
3’- ATTCACATCGGTTCTTGTCC -5’ 
95˚C x 5min, (95˚C x 10s, 60˚C x 60s) x 40 181 
    
ETB 5’- TCACTGTGCTGAGTCTATGTGC- 3’ 
3’ –AGCAGATTCGCAGATAACTTCC- 5’ 
 
95˚C x 5min, (95˚C x 10s, 60˚C x 60s) x 40 206 
FN 5’-AGCGGACCTACCTAGGCAAT-3’ 
3’-GGTTTGCGATGGTACAGCTT-5’ 
95˚C x 5min, (95˚C x 30s, 60˚C x 45s, 
72˚C x 45s) x 40 
222 
    
GAPDH 5’-TCCACCACCCTGTTGCTGTA-3’ 
3’-ACCACAGTCCATGCCATCAC-5’ 
94˚C x 5min, (94˚C x 30s, 62˚C x 30s, 
72˚C x 30s) x 30 
452 
    
ppET-1 5’-TATCAGCAGTTAGTGAGAGG-3’ 
3’-CGAAGGTCTGTCACCAATGTGC -5’ 
94˚C x 5min, (94˚C x 30s, 58˚C x 45s, 
72˚C x 30s) x 40 
181 
    
TGF-β2 5’-GGACTTTATAGTTTTCTGAT-3’ 
3’-GCCCACTTTCTACAGACCCT-5’ 
94˚C x 5min, (94˚C x 30s, 59˚C x 45s, 
72˚C x 45s) x 40 
451 
    
VEGF-A 5’-TGCAGATTATGCGGATCAAACC -3’ 
3’-TGCATTCACATTTGTTGTGCTGTAG-5’ 
95˚C x 5min, (95˚C x 15s, 60˚C x 60s) x 35 81 
 
 
Western lmmunoblot.  
 Human TM cells were lysed in 2x Laemmli's sample buffer and lysates stored at -
80°C until use. Cell culture media was collected and concentrated 2-fold by vacuum 
centrifugation and stored at -80°C until use. Proteins (10-30 µg per lane) in cell lysates or 
media were resolved by SDS-polyacrylamide gel electrophoresis and transferred onto 
Table 1. PCR Primers. PCR primer sequences with corresponding protocols and amplicon product 
sizes 
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nitrocellulose membranes as previously described.6 Membranes were blocked (5% BSA  
or 5% Blotto) and incubated overnight at 4°C in the presence of primary antibodies 
(Table 2). Washed (TBS supplemented with 0.05% Tween-20) membranes were 
incubated x 1h at 23°C in a 1:10,000 dilution of peroxidase-conjugated donkey anti-goat, 
goat anti-mouse, or goat anti-rabbit IgG secondary antibody, respectively. Following a 
final washing step, immunostained proteins were visualized by picoECL. 
Antibody Source Dilution 
   
BK B2 BD Biosciences 1:1000 
   
Caspase 3 Cell Signaling 1:1000 
   
CTGF Santa Cruz 1:500 
   
GAPDH  Cell Signaling 1:10,000 
   
pSmad2 Cell Signaling 1:1000 
   
Smad2 Cell Signaling 1:1000 
   
pSmad3 Cell Signaling 1:1000 
   
Smad3 Cell Signaling 1:1000 
Cell-Based ELISA:  
  The content of B2 receptor expressed by human TM cells was quantified using a 
cell-based ELISA as described previously.194, 195 Confluent cultures of human TM cells 
were fixed with 4% paraformaldehyde at 23ºC x 10 minutes. Fixed cells were 
subsequently permeabilized with 0.1% Triton X-100 and blocked x 1h at 23ºC with 1% 
BSA in PBS and subsequently incubated overnight at 4ºC in the presence of mouse anti-
human B2 receptor (BD Bioscience, 1/50 dilution) primary antibody. Immunostained 
cells were incubated x 1h at 23ºC with a 1/1000 dilution of horseradish peroxidase-
Table 2. Primary Antibodies. List of primary antibodies, source, and dilutions used for Western  
Immunoblot. 
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conjugated goat-anti mouse secondary antibody. Color development was initiated with 
SigmaFast OPD substrate solution x 30 min at 23ºC. Color development was stopped 
with the addition of 3N HCl and quantified at 492 nm. Relative expression of B2 receptor 
was normalized to cell density. Cell density was determined by colorimetric staining with 
Janus Green. Briefly, washed cells were treated with 0.5 N HCl x 10 min at 23ºC and 
optical density was measured at 595 nm. All groups were normalized to vehicle controls. 
 
Enzyme Linked Immunosorbent Assay. 
The content of active or total TGF-β2 or total ET-1 released into cell culture 
media were quantified using commercially-available ELISA kits (R&D Systems) as 
previously described.3, 60  Cell culture media was cleared by centrifugation (700g x 5 
min) and assayed according to manufacturer’s instruction. Latent (total) TGF-β2 was 
activated to by the addition of 1N HCL and subsequently neutralized with 1.2N 
NaOH/0.5M HEPES. The optical density was read at 450 nm with a 540nm correction. 
 
Lactate Dehydrogenase Assay. 
 Lactate dehydrogenase released by human TM cells into the culture media was 
quantified as previously described.196  Aliquots (50 µl) of collected media were added to 
96 well plates and incubated with an equal volume of assay buffer (2 mM 
iodonitrotetrazolium chlorium, 3.2 mM β-nicotinamide adenine dinucleotide sodium salt, 
160 mM lithium lactate, 15 µM 1-methoxyphenazine methosulfate in 0.2M Tris-HCl) x 
1h at 23ºC in the dark. 1 N acetic acid (50 µl) was added and formation of the colored 
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formazan product was measured spectrophotometrically by measuring absorbance at 490 
nm. 
 
Cell Viability. 
  Human TM cell viability was assessed as a function of mitochondrial redox 
potential using an MTT cell proliferation assay. Confluent human TM cells were 
incubated x 2h at 37°C in 96-well plates containing 100 µl per well of a 1.2 mM water 
soluble solution of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
prepared in HEPES-buffered (10 mM, pH 7.4) Hank’s balanced salt solution (HBSS) 
containing calcium and magnesium. Following incubation, supernatant was removed and 
insoluble formazan product was solubilized by the addition of dimethyl sulfoxide 
(DMSO). Absorbance was read at 570 nM. 
 
Immunocytochemistry. 
   Hydrostatic pressure-mediated changes in F-actin formation and 
stabilization were visualized as previously described.83 Human TM cells were fixed in 
freshly prepared phosphate-buffered (10 mM, pH 7.4) 4% paraformaldehyde (PFA) x 10 
min at 23°C followed by incubation x 20 min with 165 nM phalloidin 488 (ThermoFisher 
Scientific). Cells were counterstained with 4’,6-diamidino-2-phenyindole (DAPI) nuclear 
acidic stain and imaged utilizing a Leica TCS SPE confocal microscope and imaging 
suite.  
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Porcine Anterior Segment Perfusion. 
  Fresh porcine globes were procured from a local abattoir (Park Packing, Chicago, 
IL) and anterior segments prepared within 4-6h as described previously.60 Whole globes 
were briefly immersed in 5% povidone-iodine solution and subsequently dipped in sterile 
PBS containing 100 U/ml penicillin, 100 µg/ml streptomycin, and 1% amphotericin B. 
Aseptic globes were bisected at the equator into anterior and posterior segments. The 
posterior segment containing the vitreous body and the retina was discarded. The iris, 
lens and adjacent ciliary bodies were carefully dissected away from the anterior segment 
and the remaining segment containing the TM, cornea, and surrounding sclera were 
mounted onto a custom-made stage forming a sealed-circuit chamber (Figure 8), with the 
TM serving as the sole outflow facility. Two cannulas communicate within the chamber, 
one for media exchange and a second for real-time monitoring of intraocular pressure 
(IOP). Pairs of prepared and mounted anterior segments were continuously perfused at a 
constant flow rate of either 4.5 or 9 µl/min using DMEM supplemented with 100 u/ml 
penicillin, 100 µg/ml streptomycin, and 1% amphotericin B according to previously 
reported methods.63, 197  Segments were allowed to stabilize during the first 24h and 
cultured for an additional 24h. IOP is monitored and recorded in real-time using an 
available PowerLab 8/35 high-performance data acquisition system supplied with 
LabChart Pro software. IOP data are reported as mean mmHg ± SEM. Following 
perfusion, porcine TM was harvested and changes in gene expression were analyzed by 
qRT-PCR as described above. 
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Figure 8. Porcine Anterior Segment Perfusion (A) Schematic 
representation of porcine anterior segment perfusion apparatus. (B) 
Custom made stage prior to, and after (C) mounting of porcine 
segment. 
 
 
 
C. 
A. 
C. B. 
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CHAPTER THREE 
RESULTS 
 
TGF-β2 Selectively Alters Matricellular and ECM Gene Expression in Primary and 
Transformed Human TM Cells.  
   Previously published studies from our laboratory confirm a causal role of 
biologically active TGF-β2 in elevating IOP in patients with POAG.60, 86, 99 While not 
fully understood, the mechanism by which TGF-β2 elevates IOP is thought to involve 
altered expression and secretion of matricellular and structural ECM proteins. 
Challenging transformed (GTM3, NTM5) or primary human TM cells with biologically 
active TGF-β2 (5 ng/ml, x 24h) markedly increased (2-6 fold) the mRNA content of the 
CTGF (Table 3) when compared with vehicle (200 nM HCl) treated controls, consistent 
with previously published studies.47 Given that CTGF is a critical downstream regulator 
of TGF-β2 mediated signaling, this matricellular protein has also been strongly 
implicated in the pathogenesis of various fibrotic diseases, including POAG.120, 121 In 
addition, exogenous TGF-β2 also markedly and selectively enhanced (2-12 fold) the 
mRNA expression of several structural ECM protein subunits, including Col1α1, Col1α2, 
and Col4, in both transformed and primary human TM cells (Table 3). Not all structural 
ECM protein subunits, however, were altered by TGF-β2 treatment. While human TM 
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cells expressed measurable levels of Col6, this subtype was unaffected by TGF-β2 
treatment. By comparison, primary human TM cells responded to TGF-β2 treatment by  
notably increasing (2.25-fold) fibronectin (FN) mRNA content (Table 3). 
  Table 3. TGF-β2 alters gene expression in human TM cells. Primary (hTM) or transformed (GTM3, 
NTM5) TM cells were conditioned in serum-free media (x24h), and subsequently cultured in the absence 
(200 nM HCl) or presence of TGF-β2 (5 ng/ml, x24h). Relative mRNA content was quantified by qRT-
PCR. Data shown are GAPDH-normalized fold changes expressed as the mean ± SEM (N=3-6).  * p 
<0.05 compared to vehicle control, unpaired Student’s t-test. 
  nd: not detectable 
 
Transformed TM cells, however, only marginally (or not all) altered FN mRNA content 
following treatment with exogenous TGF-β2. The expression of the structural ECM 
protein subunit Col2α1 and matricellular proteins TGF-β2 and vascular endothelial 
 hTM NTM5 GTM3 
Gene mRNA content  
     (% veh) 
N mRNA content  
     (% veh) 
N mRNA content  
     (% veh) 
N 
ECM Component      
       
Col1α1  290 ± 19%* 4  268 ± 4%* 3  1219 ± 30%* 6 
Col1α2  238 ± 14%* 4  234 ± 16%* 3  400 ± 64%* 6 
Col2α1  135 ±  50% 4  51 ± 21%* 3  74 ± 10% 6 
Col4  190 ± 17%* 4  341 ± 67%* 3  1043 ± 163%* 6 
Col6  83 ± 25% 4  100 ± 12% 3  91 ± 17% 6 
FN  225 ±  35%* 4  60 ± 21% 3  133 ± 4%* 6 
       
Matricellular Proteins      
       
CTGF  383 ± 27%* 4  194 ± 25%* 3  586 ± 75%* 6 
ppET-1  238 ± 23%* 4  852 ± 103%* 3 1184 ± 26%* 6 
TGF-β2  130 ± 21% 4  116 ± 15%* 3  130 ± 35% 6 
VEGF-A  107 ± 26% 4  134 ± 23% 3  90 ± 11% 6 
       
Receptors       
       
BK B1  43 ± 9%* 5  48 ± 7%* 5  36 ± 14%* 5 
BK B2  24 ± 15%* 5  29 ± 27%* 5  40 ± 14%* 5 
ETA  17 ± 13%* 4  43 ± 6%* 3  61 ± 13%* 3 
ETB nd 4 nd 3 nd 3 
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growth factor (VEGF)-A was not appreciably affected by TGF-β2 treatment in primary or 
transformed human TM cells.  
   Given that AH harvested from some POAG patients also contains elevated levels 
of ET-1,94, 96 we investigated a possible mechanistic link exists between TGF-β2 
signaling and ET-1 expression. Primary human TM cells challenged with TGF-β2 
exhibited a 2.4-fold increase in ppET-1 mRNA content that was even more robustly (8-12 
fold) observed in transformed human TM cell lines. While TGF-β2 mediated increases in 
secreted ET-1 were not quantified here, previously studies from our laboratory have 
demonstrated that TGF-β2 increases both the synthesis and secretion of ET-1 from 
human TM cells.99 Concomitantly, TGF-β2 treatment decreased, by as much as 80%, 
ETA receptor mRNA content (Table 3) in primary and transformed human TM cells. ETB 
receptor mRNA, however, was not appreciably expressed in human TM cells consistent 
with previous reports.108 The expression of the ETB receptor protein by cultured human 
TM cells, however, has been reported.107, 108 
 
TGF-β2 Attenuates Constitutive Bradykinin Receptor Expression in Primary and 
Transformed Human TM Cells.  
  BK, a short-lived nonapeptide known for its potent vasoactive properties, is a 
well-documented regulator of IOP whose activity may very well be influenced by TGF-
β2 signaling. Activation of the B2 receptor lowers IOP in a number of experimental 
models of glaucoma.29, 130, 131 Given the hypotensive efficacy of BK and its importance as 
a potentially valuable therapeutic option, we investigated the effect TGF-β2 signaling 
elicits on kallikrein-kinin system in human TM cells. Recently, Sharif et al. reported that 
43	
0 .0
0 .5
1 .0
1 .5
** **
TGF-β2 reduces the expression of B2 receptor mRNA in cultured human TM cells.130 In 
our hands, primary and transformed human TM cells similarly responded to TGF-β2 (5 
ng/ml, x24h) by reducing the constitutive expression of both B1 and B2 receptor mRNA 
by as much as 75% (Table 3). Importantly, TGF-β2 (5 ng/ml, x24h) also elicited a 60% 
reduction in constitutive expression of B2 receptor protein content in human TM cells, 
when compared to vehicle controls (Figure 9C, D). The effect of TGF-β2 was both dose- 
and time-dependent. Whereas relatively low doses of TGF-β2 (1-2.5 ng/ml, x24h) were 
without effect on B2 receptor content, a higher dose (5 ng/ml) was seen to significantly 
attenuate B2 receptor protein expression (Figure 9A). 
 
	
 
 
 
 
 
 
 
 
  
Figure 9. TGF-β2 decreases constitutive expression of B2 receptor protein. Transformed (GTM3) TM 
cells were conditioned in serum-free media (x24h), and subsequently cultured in the absence (200 nM HCl) 
or presence of TGF-β2 (1-5 ng/ml, 0-48h) as indicated. (A, B) Relative expression of the B2 receptor in 
GTM3 cells treated with TGF-β2 (0-5 ng/ml, x0-48h) as indicated. (C) Western Immunoblot and (D) 
quantitative comparison of B2 receptor in cell lysates from both GTM3 and NTM5 cell lines. Data shown 
are normalized changes from 2 independent experiments and expressed as the mean ± SEM (N=5-8). * p 
<0.05 relative to vehicle control, One-way ANOVA with a Bonferroni’s post hoc analysis; ** p <0.05 
relative to vehicle control, Student’s t-test. 
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The effect of TGF-β2 (5 ng/ml) on B2 receptor protein expression was not immediate, 
taking 24h to first manifest itself and persisting through 48h (Figure 9B). Unlike the 
constitutively expressed B2 receptor, the B1 receptor is inducible, typically expressed at 
the protein level in response to trauma or inflammation.  In vitro, treating human TM 
cells with B1 receptor specific agonists fails to elicit a functional response and, to date, 
the B1 receptor has not been localized, at the protein level, to any ocular tissues.130 In our 
hands, B1 receptor protein was not expressed to a measurable extent in either primary or 
transformed human TM cells.  
 
TGF-β2 Utilizes the Canonical Smad3-dependent Pathway to Attenuate B2 
Receptor Expression. 
  Previous studies from our lab, and others, have identified a unique non-canonical 
role for the Rho subfamily of small monomeric GTPases in mediating TGF-β2 
downstream signaling events involved in regulating cytoskeletal organization.60, 83 In 
addition, RhoA has also been shown to play a role in regulating gene transcription, 
although the mechanism of this regulation is not fully understood. To determine if the 
Rho GTPase subfamily of proteins play a role in TGF-β2 mediated decreases in B2 
receptor content, primary or transformed TM cells were pretreated (x1h) with vehicle 
(dH2O) or C3 exoenzyme (10 µM) and subsequently cultured in the absence or presence 
of TGF-β2 (5 ng/ml, x24h). As we previously observed, TGF-β2 markedly attenuated B2 
receptor mRNA content by as much as 90% in primary or transformed GTM3 cells 
(Table 4). Pre-treating cells with C3 exoenzyme (a cell permeable pan inhibitor of the 
Rho GTPases) did not, however, prevent TGF-β2 from attenuating B2 receptor mRNA 
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content in human TM cells. These findings suggest that TGF-β2 elicits a decrease in B2 
receptor expression by a mechanism that occurs independently of non-canonical Rho 
GTPase signaling.  	
TM Cell Type Treatment BK B2 receptor  
mRNA content 
N 
hTM 
(primary) 
Vehicle  100 ±  27% 3 
TGF-β2 (5 ng/ml)  8  ± 2%* 3 
C3 + TGF-β2 (5ng/ml)  10 ± 3%* 3 
GTM3 
(transformed) 
Vehicle  100  ±  24% 6 
TGF-β2 (5 ng/ml)  58  ± 25*  6 
C3 + TGF-β2 (5ng/ml)  43  ±  8 * 6 
Table 4. TGF-β2 attenuates B2 receptor expression independently of Rho GTPase signaling. 
Primary (hTM) or transformed (GTM3) TM cells were conditioned in serum-free media (x24h), 
pretreated with vehicle (dH2O) or C3 exoenzyme (10 µM, 1h) as indicated, and subsequently cultured in 
the absence (200 nM HCl) or presence of TGF-β2 (5 ng/ml, x24h). Relative content of B2 receptor 
mRNA was quantified by qRT-PCR. Data shown are GAPDH-normalized fold changes from 1-2 
experiments and expressed as the mean ± SEM (N=3-6). * p <0.05 relative to vehicle control, One-way 
ANOVA with a Bonferroni’s post hoc. 
 
Targeted, siRNA mediated knockdown of Smad2 or Smad3 expression was next 
utilized to determine the role of the canonical R-Smad dependent signaling pathway in 
mediating TGF-β2 decreases in B2 receptor content. Primary or transformed human TM 
cells were transfected with either Smad2 (25 nM), Smad3 (10 nM), or control scrambled 
(25 nM) siRNA and subsequently cultured in the absence or presence of TGF-β2 (5 
ng/ml, x24h). In the presence of control scrambled siRNA, TGF-β2 reproducibly and 
significantly attenuated constitutive B2 receptor mRNA and protein expression (Figure 
10A, B). In contrast, transfecting TM cells with Smad3 siRNA completely prevented 
TGF-β2 mediated decreases in both B2 receptor mRNA and protein content (Figure 10A, 
B). Unexpectedly, transfecting TM cells with Smad2 slightly attenuated TGF-β2 
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mediated decreases in B2 mRNA, although not to a statistically significant level. By 
comparison, selective knockdown of Smad2, however, had no effect on TGF-β2 mediated 
decreases in B2 receptor protein expression. (Figure 10A, B).  															 	
Figure 10. TGF-β2 mediated attenuation of the B2 receptor selectively involves the canonical 
Smad3-dependent pathway.  Primary (hTM) or transformed (GTM3) TM cells were transfected (x24h) 
in serum-free media with control scrambled (25 nM), Smad2 (25 nM) or Smad3 siRNA (10 nM), and 
subsequently cultured in the absence (200 nM HCl) or presence of TGF-β2 (5 ng/ml, 24h), as indicated. 
Relative content of B2 receptor (A) mRNA and (B) protein was quantified by qRT-PCR and cell based 
ELISA, respectively. (C)  siRNA knockdown of Smad2 and Smad3 was confirmed via Western 
immunoblot.  Data shown are GAPDH-normalized fold changes from 1-2 experiments and expressed as 
the mean ± SEM (N=2-6). * p <0.05, One-way ANOVA with a Bonferroni’s post hoc analysis. 
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As shown in Figure 10C, transfecting human TM cells with Smad2 or Smad3 siRNA 
nearly abolished the expression of total and phosphorylated Smad2 or total and 
phosphorylated Smad3 proteins, respectively. Moreover, knockdown of either Smad2 or 
Smad3 did not elicit a compensatory change in the expression level of the other R-Smad 
(Figure 10C). Selective knockdown of either R-smad in the absence of TGF-β2 elicited 
similar results (data not shown). Collectively, these findings demonstrate that TGF-β2 
elicits a decrease in the expression of the B2 receptor in human TM cells by selectively 
activating the canonical Smad3 dependent pathway. Whereas both Smad2 and Smad3 are 
measurably expressed within human TM cells, the mechanism by which TGF-β2 
selectively recruits Smad3 in this process remains unclear.     
   TGF-β2 may selectively degrade B2 receptor expression in human TM cells by 
invoking one of many possible pathways, including altered expression of the B2 receptor 
gene, altered stability of B2 receptor mRNA, or even facilitation of B2 receptor protein 
sequestration and degradation. To determine which, if any, of these possible mechanisms 
are responsible, transformed human TM cells were conditioned in serum free media 
(x24h), pre-treated with the transcription inhibitor actinomyocin D (1 µg/ml, x1h), and 
subsequently cultured in the absence (200 nM HCl) or presence of TGF-β2 (5 ng/ml) for 
up to 24h. Pre-treatment with actinomyocin D elicited a time-dependent decrease in 
endogenous B2 receptor mRNA content with a qualitative half-life of approximately 3h 
(Figure 11). Challenging cells with TGF-β2 did not appreciably alter degradation of B2 
receptor mRNA content, suggesting that TGF-β2 does not reduce B2 receptor protein 
levels by affecting B2 receptor mRNA stability. From these findings, we speculate that 
TGF-β2 most likely attenuates B2 receptor expression in human TM cells either by 
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inhibiting gene transcription or by facilitating the degradation of the B2 receptor protein. 
On-going studies using a variety of biochemical inhibitors including the protein synthesis 
inhibitor cycloheximide, autophagosomal/lysosomal proteolytic pathway inhibitors 
(ammonium chloride, chloroquine, 3-methyl adenine, wortmannin), and proteasomal 
inhibitors (lactacystin, epoxomicin) should help elucidate this mechanism (Von Zee and 
Stubbs, 2011). The functional consequence of decreased B2 receptor expression in the 
human TM has yet to be explored. 
 				 	
 
 
Figure 11. TGF-β2 attenuates B2 receptor mRNA independently of mRNA stability. Transformed 
(GTM3) TM cells were conditioned in serum-free media (x24h), pretreated with actinomyocin D (1 
µg/ml, x30m), and subsequently cultured in the absence (200 nM HCl) or presence of TGF-β2 (5 ng/ml, 
x24h). Relative content of B2 receptor mRNA was quantified by qRT-PCR. Data shown are GAPDH-
normalized fold changes from 2 experiments and expressed as the mean ± SEM (N=6). * p <0.05, 
unpaired Student’s t-test. 	
Elevated Hydrostatic Pressure Induces Cell Stress in Human TM Cells.	 
   The TM maintains IOP within physiologic levels (~15 mmHg) by dynamically 
responding to constantly changing hydrostatic pressures.153, 154 Mechanisms that govern 
these responses directly influence AH outflow resistance through the TM by altering the 
actin cytoskeleton and changing ECM expression level or composition.19, 99 While the 
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mechanism by which TGF-β2 increases AH outflow resistance through the TM has been 
well studied, the effect of sustained mechanical stress on the TM in response to elevated 
IOP is not as well understood. Chronic over activation of homeostatic mechanisms 
designed to maintain IOP elicits a permanent change in the morphology and extracellular 
milieu of the TM. Previous studies examining TM cell responses to mechanical stress 
have largely focused on the effect of physical stretch or fluid sheer stress on TM cells,46, 
158, 198 while neglecting the role of elevated hydrostatic pressure in POAG. To better 
understand the effect elevated hydrostatic pressure may elicit on the conventional outflow 
pathway, human TM cells were conditioned in serum free media (x24h), and 
subsequently cultured at ambient (atmospheric 760 mmHg) or elevated (+30 mmHg 
above atmospheric) hydrostatic pressures.   
   Previous reports, conducted in other ocular cell types, showed that short-term 
(<24h) exposure to elevated hydrostatic pressure induces mitochondrial dysfunction, 
while more prolonged exposures (≥ 24h) often induce apoptosis.177, 178 By comparison, 
culturing human TM cells under a controlled sealed atmosphere of 95% air / 5% CO2 at 
elevated hydrostatic pressure (+30 mmHg, up to 12h) only marginally diminished 
mitochondrial function as quantified by MTT reduction (Figure 12A). In contrast, 
prolonged exposure of human TM cells to elevated hydrostatic pressure (24h) elicited a 
marked decrease in MTT reduction (51%), suggestive of mitochondrial dysfunction. 
Elevated hydrostatic pressure also elicited an initial modest increase in LDH secretion 
(up to 12h) from human TM cells that was similarly enhanced during prolonged (24h) 
exposure (Figure 12B), consistent with increased cell stress.  
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Figure 12. Elevated hydrostatic pressure induces cellular stress in transformed TM cells.  GTM3 
cells were conditioned in serum-free media (x24h) and subsequently cultured at ambient or elevated 
hydrostatic pressure (+30mmHg, 1.5-24h). Mitochondrial function and membrane permeability were 
assessed by (A) MTT reduction and (B) LDH release, respectively. In both cases, relative values were 
normalized to ambient pressure controls. Data shown are normalized changes expressed as the mean ± 
SEM (N=8)., * p <0.05, Two-way ANOVA with a Bonferroni’s post hoc. (C) Western Immunoblot of 
total and cleaved Caspase 3. Levels of GAPDH are shown for comparison as loading controls.  
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MTT reduction and LDH release are often used as measures of cell viability. 
More accurately, however, these assays quantify NAD(P)H-dependent cellular 
oxidoreductase (mitochondrial metabolism) and plasma membrane integrity/permeability, 
respectively. To directly assess whether elevated hydrostatic pressure effects human TM 
cell viability, caspase 3 cleavage (an indicator of caspase 3 activation and apoptosis) was 
quantified by Western immunoblot. Levels of total caspase 3 in human TM cells exposed 
to elevated hydrostatic pressure (+ 30 mmHg, x1.5-24h) remained constant with no 
evidence of cleavage/activation (Figure  12C). In addition, no significant changes in cell 
densities were observed in response to elevated hydrostatic pressure at these time points 
(data not shown). Following prolonged (48h) exposure to elevated hydrostatic pressure, 
however, human TM cells exhibited a marked increase in the levels of cleaved caspase 3 
(Figure 12C). Collectively, these findings suggest that exposing human TM cells to 
pathophysiological levels of elevated hydrostatic pressures time-dependently elicits 
cellular (possibly oxidative) stress leading to apoptosis. Further studies were limited to 
24h hours in order to characterize TM cell responses to elevated hydrostatic pressure 
prior to the onset of apoptosis.  
 
Elevated Hydrostatic Pressure Alters the Actin Cytoskeleton in Human TM Cells. 
   Elevated IOP is strongly associated with the enhanced formation of actin stress 
fibers, increasing rigidity and stiffness of the TM, ultimately leading to greater resistance 
to AH outflow.88, 90, 99 In vitro, either mechanical stretch or treatment with TGF-β2 
increases actin stress fiber formation in human TM cells.99, 165 The effect of elevated 
hydrostatic pressure on the actin cytoskeleton, however, has not been previously reported. 
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Exposing transformed human TM cells to elevated hydrostatic pressure (+30 mmHg, 3h 
or 24h) markedly increased phalloidin positive (filamentous-actin, F-actin) staining when 
compared to ambient pressure controls (Figure 13A-D). By comparison, the re-
organization of F-actin elicited by exposure to elevated hydrostatic pressure was 
distinctly unique (appearing more punctate and nuclear) from that induced by exogenous 
TGF-β2 (Figure 13E, F). Human TM cells treated with TGF-β2 (5 ng/ml) at ambient 
pressures exhibited increased formation of actin stress fibers, consistent with previously 
published studies.99, 199  											
Figure 13. Elevated hydrostatic pressure alters the actin cytoskeleton in transformed TM cells.  
Transformed (GTM3) TM cells were conditioned in serum-free media (x24h) and subsequently cultured 
at (A, B) ambient or (C, D) elevated pressure (+30 mmHg) for 3 or 24h, as indicated. (E, F) Shown for 
comparison are GTM3 cells treated with TGF-β2 (5 ng/ml, 3 or 24h) at ambient pressure. Filamentous 
actin was visualized with phalloidin (green) and counterstained with DAPI (blue).  
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Elevated Hydrostatic Pressure Selectively Alters Gene Expression in Human TM 
Cells. 
  In addition to remodeling the actin cytoskeleton, exposing human TM cells to 
elevated hydrostatic pressure may also elicit changes in gene transcription.46 To 
determine whether exposing TM cells to elevated hydrostatic pressure affects gene 
expression, transformed TM cells were conditioned in serum free media (x24h) and 
subsequently cultured at ambient or elevated hydrostatic pressure (+30 mmHg, x6h). 
Using a commercially available pre-designed “POAG” nanoarray, we simultaneously 
measured changes in the expression of 16 different genes previously reported to be 
involved in the pathogenesis of POAG. The expression of 12 of 16 genes measured, 
including TGF-β1, was not significantly affected by exposure to elevated hydrostatic 
pressure (Figure 14).  
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Figure 14. Elevated hydrostatic pressure elicits selective changes in gene expression. Transformed 
(GTM3) TM cells were conditioned in serum-free media (x 24h), and subsequently cultured at ambient 
or elevated hydrostatic pressure (+30 mmHg, x 6h). Relative changes in mRNA content were analyzed 
by qRT-PCR utilizing a commercially available, predesigned “POAG” nanoarray. Data shown are the 
mean fold-changes ± SEM (n=4) from two independent experiments. * p<0.05 relative to ambient 
pressure control, Student’s t-test.  
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Periostin (POSTN), a matricellular ECM protein involved in ECM remodeling, 
was below the level of detection in transformed TM cells cultured under either condition. 
By comparison, exposing TM cells to elevated hydrostatic pressure (+30 mmHg, x 6h) 
elicited statistically significant increases in cyclin dependent kinase inhibitor (CDKN) 1a 
(2.5-fold), VEGF- A (5.9-fold) and CTGF (9.9-fold), when compared to ambient pressure 
controls. These results demonstrate for the first time that elevated hydrostatic pressure 
selectively induces changes in gene expression in human TM cells. 
   Novel findings from this study demonstrate that TM cells respond to elevated 
hydrostatic pressure by upregulating CTGF, a known downstream regulator of TGF-β2 
mediated gene expression signaling events (Table 3, Figure 14). To better understand the 
sequence of molecular events, the time course by which elevated hydrostatic pressure 
elicits selective changes in gene expression was characterized (Figure 15).When 
compared to ambient pressure controls, both primary and transformed human TM cells 
responded to elevated hydrostatic pressure by rapidly (<1.5h) increasing CTGF mRNA 
expression (Figure 15A, B) and by releasing (~6h) measurable levels of CTGF protein 
into the culture media both of which were sustained for 24h. By comparison, the 
enhanced expression of endogenous TGF-β2 mRNA induced by elevated hydrostatic 
pressure lagged behind that of CTGF mRNA expression, being first detectable at ~3h, 
peaking at 6h, and returning to baseline levels by 24h (Figure 16A). Release of total or 
active TGF-β2 into the culture media, however, continued to increase throughout the 24h 
assayed (Figure 16 B, C). Secreted TGF-β2 from primary human TM cells in response to 
elevated hydrostatic pressure was below the level of detection at all time points tested. 
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Figure 15.  Elevated hydrostatic pressure increases CTGF mRNA content and protein secretion. 
Primary (hTM) or transformed (GTM3) human TM cells were conditioned in serum-free media (x24h), 
and subsequently cultured at ambient or elevated hydrostatic pressure (+30 mmHg, 1.5-24h). (A)  
Relative GAPDH-normalized changes in CTGF mRNA content were quantified by qRT-PCR. (B) 
Secreted CTGF was visualized by Western immunoblot. Data shown are from 1-2 separate experiments 
and expressed as the mean ± SEM (N=3-6).  * p <0.05 relative to ambient pressure control, Two-way 
ANOVA with a Bonferroni’s post hoc analysis. 
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Figure 16.  Elevated hydrostatic pressure transiently increases TGF-b2 mRNA content and protein 
secretion. Primary (hTM) or transformed (GTM3) cells were conditioned in serum-free media (x24h), 
and subsequently cultured at ambient or elevated hydrostatic pressure (+30 mmHg, 1.5-24h). (A) 
Relative GAPDH-normalized fold changes in TGF-b2 mRNA content was quantified by qRT-PCR. (B) 
Secreted total TGF-β2 and (C) active TGF-β2 were quantified by ELISA.  Data shown are from 1-2 
separate experiments and expressed as the mean ± SEM (N=3-6).  * p <0.05 relative to ambient pressure 
control, Two-way ANOVA with a Bonferroni’s post hoc analysis. 
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Both primary and transformed TM cells also responded to elevated hydrostatic 
pressure by rapidly (<1.5h) increasing ppET-1 mRNA expression (Fig. 17A). Unlike 
CTGF expression, however, changes in ppET-1 mRNA levels were transient, returning to 
control levels by 24h. Secreted ET-1 levels peaked at ~6h before returning to the levels of 
ambient pressure control by 24h in both primary or transformed TM cells (Fig. 17B). 
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Figure 17.  Elevated hydrostatic pressure transiently enhances ppET-1 mRNA and secreted ET-1 
content. Primary (hTM) or transformed (GTM3) human TM cells were conditioned in serum-free 
media (x24h), and subsequently cultured at ambient or elevated hydrostatic pressure (+30 mmHg, 1.5-
24h). (A)  Relative GAPDH-normalized-fold changes in ppET-1 mRNA content were quantified by 
qRT-PCR. (B) Secreted ET-1 was quantified by ELISA. Data shown are from 1-2 separate experiments 
and expressed as the mean ± SEM (N=3-6).  * p <0.05 relative to ambient pressure control, Two-way 
ANOVA with a Bonferroni’s post hoc analysis. 
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  We also examined the effect of elevated hydrostatic pressure on the expression of 
bradykinin B1 or B2 receptors and endothelin A receptors, of which all three are 
constitutively expressed by human TM cells at the mRNA level.108, 130 Both primary and 
transformed human TM cells exposed to elevated hydrostatic pressure (+30 mmHg) 
exhibit a rapid (<1.5h) increase in B1 receptor mRNA content (Figure 18A). This effect 
was sustained in primary TM cells but transient in transformed cells. By comparison, a 
differential effect was observed for B2 receptor mRNA content. Primary TM cells 
responded to elevated hydrostatic pressure by inducing a rapid (<1.5h), yet transient, 
increase in B2 receptor mRNA expression (Figure 18B). Elevated hydrostatic pressure 
had no effect on B2 receptor expression in transformed TM cells, highlighting unique 
differences between primary and transformed human TM cells.   
  In contrast to changes in bradykinin receptor mRNA expression, both primary and 
transformed TM cells exposed to elevated hydrostatic pressure exhibit a time-dependent 
sustainable decrease in ETA receptor mRNA expression (Figure 18C). Endogenous 
expression of the ETB mRNA in primary or transformed TM cells, however, was 
unaffected by elevated hydrostatic pressure, remaining below the level of detection in 
either cell type. 
Consistent with changes seen on our “POAG” nanoarray (Figure 14), elevated 
hydrostatic pressure also induced a transient increase in VEGF-A mRNA content, with 
this response being more robust in transformed TM cells (Fig. 18 D). Interestingly, the 
time course for pressure-induced changes in VEGF-A expression was qualitatively 
similar with that observed for TGF-β2. Earlier studies support a role for VEGF-A in the 
regulation of IOP200 as well as in the pathophysiology neovascular glaucoma, a secondary 
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glaucoma associated with neovascularization of the iris.201, 202 Our findings are consistent 
with these reports. In addition, these findings suggest that elevated hydrostatic pressure 
may initiate neovascular changes within the TM, and particularly Schlemm’s canal, 
which may hinder AH outflow and contribute to elevated IOP in affected patients. 
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Figure 18.  Elevated hydrostatic pressure induces time-dependent changes in gene expression. 
Primary (hTM) or transformed (GTM3) human TM cells were conditioned in serum-free media (x24h), 
and subsequently cultured at ambient or elevated hydrostatic pressure (+30 mmHg, 1.5-24h). (A)  
Relative GAPDH-normalized fold changes in mRNA content was quantified by qRT-PCR (B) Secreted 
ET-1 was quantified by ELISA. Data shown are from 1-2 separate experiments and expressed as the 
mean ± SEM (N=3-6).  * p <0.05 relative to ambient pressure control, Two-way ANOVA with a 
Bonferroni’s post hoc analysis. 
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As previously noted, human TM cells also exhibit marked changes in the 
expression of several ECM related genes following a TGF-β2 challenge (Table 3) or 
within TM tissue harvested from POAG patients.53, 54 In vitro studies strongly support a 
causal role for both TGF-β2 and mechanical stretch in eliciting altered ECM content.14, 46 
We found that exposing primary or transformed human TM cells to elevated hydrostatic 
pressure differentially alters ECM mRNA content in a time-dependent manner (Figure 
1). Primary TM cells exposed to elevated hydrostatic pressure exhibit rapid (<1.5h), yet 
transient, increases in Col1a1, Col2a1, Col4, and FN (Figure 19A, C, D, F) mRNA 
content. By comparison, expression of Col1α1, Col2α1, Col4, or fibronectin in 
transformed TM cells was largely unaffected by exposure (1.5h-24h) to elevated 
hydrostatic pressure. The expression of Col1α2 in both primary and transformed TM cells 
responding to elevated hydrostatic pressure was uniquely different, being reduced over 
the time-course of 24h (Figure 19B). Col6 expression remained unaltered in primary or 
transformed TM cells by exposure to elevated hydrostatic pressure for up to 12h 
However, prolonged exposure (x24h) of transformed TM cells to elevated hydrostatic 
pressure elicited a marked increase in Col6 mRNA expression (Figure 19E). 
To gain a more complete understanding of the effect of elevated hydrostatic 
pressure on gene expression relevant to ECM remodeling, we utilized a commercially 
available, predesigned “ECM remodeling” nanoarray. Notably, in primary TM cells, 
elevated hydrostatic pressure (+30 mmHg, x 6h) elicited increased expression in only 3 of 
the 38 genes measured (Table 5).  These genes included structural growth factors 
(Heparin-binding EGF-like growth factor, Insulin-like growth factor 2), proteases 
(MMP3), and inhibitors of proteases (SERPINE1) gene expression by human TM cells, 
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consistent with remodeling of the ECM in POAG. The expression of 24 of the genes 
measured was not significantly altered by exposure to elevated hydrostatic pressure while 
the remaining 11 were below the level of detection under either condition. 
 
 	 													
 
 
Figure 19. Extracellular matrix mRNA expression is altered in response to elevated hydrostatic 
pressure. Primary (hTM) or transformed GTM3 cells were conditioned in serum-free media (x24h), and 
subsequently cultured at ambient or elevated hydrostatic pressure (+30 mmHg, x1.5-24h) as indicated. 
Relative mRNA content was quantified by qRT-PCR. Data shown are GAPDH-normalized fold changes 
from 1-2 independent experiments and expressed as the mean ± SEM (N=3-6).  * p <0.05 relative to 
ambient pressure control, Two-way ANOVA with a Bonferroni’s post hoc analysis. 
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Exposure to Clinically Relevant Hydrostatic Pressure Loads Increases ET-1,  
TGF-β2 and CTGF Expression as well as ET-1 Release. 
   Human TM cells respond to elevated hydrostatic pressure by altering their actin 
cytoskeleton and selectively and differentially changing their matricellular/ECM mRNA 
expression/stability (Figures 15-19, Table 5). The relationship between a given 
 Ambient Pressure Elevated Pressure 
(+ 30 mmHg) 
Gene mRNA content 
(x̅ ±SEM) 
N mRNA content 
(x̅ ±SEM) 
N 
CD44 100 ± 15% 3 86% ± 13% 3 
Col1α1 100 ± 25% 3 134 ± 34% 3 
Col1α2 100 ± 13%* 3 131 ± 13% 3 
Col3α1 100 ± 15% 3 105 ± 16% 3 
Col4α2 100 ±  24% 3 130 ± 28% 3 
Col4α3 ND 3 ND 3 
EGFR 100 ±  10% 3 100 ± 10% 3 
ERBB ND 3 NA 3 
EZR 100 ±  31% 3 111 ± 34% 3 
FN1 100 ±  18% 3 61 ± 11% 3 
HB-EGF 100 ±  18% 3 839 ± 153%* 3 
IGF1 ND 3 ND 3 
IGFR1 100 ±  33% 3 123 ± 40% 3 
IGF2 100 ±  12% 3 513 ± 60%* 3 
IL8 100 ±  16% 3 148 ± 24% 3 
ITGB1 100 ±  17% 3 136 ± 23% 3 
KLK3 ND 3 ND 3 
LAMC2 ND 3 ND 3 
MMP1 100 ±  16% 3 111 ± 18% 3 
MMP2 100 ±  16% 3 63 ± 10% 3 
MMP3 100 ±  18% 3 651 ± 116%* 3 
MMP7 ND 3 ND 3 
MMP9 ND 3 ND 3 
MMP13 ND 3 ND 3 
MMP14 100 ±  22% 3 119 ± 26% 3 
MSN 100 ±  22% 3 88 ± 19% 3 
PAI-1 100 ±  24% 3 293 ± 61% 3 
PAI-2 100 ±  18% 3 145 ± 27% 3 
PLAT 100 ±  35% 3 190 ± 65% 3 
PLAU 100 ±  49% 3 139 ± 67% 3 
PLAUR 100 ±  11% 3 110 ± 12% 3 
PLG ND 3 ND 3 
SPARC 100 ±  15% 3 55% ± 11% 3 
TIMP1 100 ±  15% 3 98 ± 16% 3 
TIMP2 100 ±  20% 3 103 ± 21% 3 
TIMP 100 ±  15% 3 123 ± 19% 3 
VCAN 100 ±  32% 3 71 ± 22% 3 
VTN ND 3 ND 3 
Table 5. Elevated hydrostatic pressure elicits selective changes in the expression of genes relevant 
to ECM remodeling. Primary (hTM) cells were conditioned in serum-free media (x 24h), and 
subsequently cultured at ambient or elevated hydrostatic pressure (+30 mmHg, x6h). Relative changes 
in mRNA content were analyzed by qRT-PCR utilizing a commercially available, predesigned “ECM 
remodeling” nanoarray Data shown are the mean fold-changes ± SEM (N=3). * p<0.05 relative to 
ambient pressure control, Student’s t-test         
ND = not detected 
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hydrostatic pressure load and the resulting cellular responses to such a challenge in vitro 
must, however, be carefully considered when interpreting these findings. For example, 
previous studies have shown that exposing chondrocytes to low levels (2.5 MPa) of 
hydrostatic pressure elicits an increase in proteoglycan synthesis, while higher levels (7.5 
MPa) of hydrostatic pressure were found to inhibit gene transcription.203, 204 In vivo, 
human TM cells constantly experience small diurnal and pulsatile fluctuations in 
hydrostatic pressures much smaller than hydrostatic pressures typically applied in an 
experimental setting.205 Together, these reports raise important questions regarding 
whether human TM cells will respond to a more clinically relevant change in hydrostatic 
pressure and if various pressure loads/levels will elicit a differential response, similar to a 
pharmacological dose response to a given ligand.   
To determine whether human TM cells respond differentially to clinically relevant 
and increasing levels of elevated hydrostatic pressure, cells were conditioned in serum 
free media and exposed (x 6h) to ambient or low (+15 mmHg), elevated (+30 mmHg), or 
high (+45 mmHg) hydrostatic pressures. Compared to ambient controls, exposing TM 
cells to changes in hydrostatic pressure low as 15 mmHg significantly upregulated TGF-
β2, CTGF, and ppET-1 mRNA content (Figure 20 A-C) and ET-1 release (Figure 20E), 
consistent with previously observed changes (Figures 15-17).  Expression and release of 
these matricellular proteins in response to hydrostatic pressure was maximal at 15 
mmHg, with no further increase seen up to 45 mmHg tested (Figure 20 D, E). These 
cellular responses appeared to be selective, as release of total TGF-β2 was not 
significantly altered by exposure (x6h) to any level of increased hydrostatic pressure 
(Figure 20D) as previously observed (Figure 16). 
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Figure 20.  Clinically relevant changes in hydrostatic pressure alter matricellular mRNA 
expression and ET-1 release. Transformed (GTM3) TM cells were conditioned in serum-free media 
(x24h), and subsequently cultured at ambient or elevated hydrostatic pressure (+15-45 mmHg, x6h) as 
indicated. (A-C) Relative mRNA content was quantified by qRT-PCR and normalized to GAPDH. (D) 
Total TGF-β2 and (E) secreted ET-1 were quantified by ELISA. Data shown are from 2 independent 
experiments and expressed as the mean ± SEM (N=6).  * p <0.05 relative to ambient pressure control, 
Two-way ANOVA with a Bonferroni’s post hoc analysis. 
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Inhibition of ETB Receptor Activation Prevents Elevated Hydrostatic Pressure 
Mediated Increases in TGF-β2 and ET-1, but not CTGF, mRNA Expression.  
   Previously, we have reported that human TM cells respond to exogenous TGF-β2 
(5 ng/ml, x24h) by robustly increasing both ppET-1 and CTGF mRNA expression.47, 99 
These findings are consistent with CTGF being known as a key intermediate regulator of 
TGF-β2 dependent gene expression signaling pathways.124 The mechanism(s) by which 
physiological/elevated hydrostatic pressure elicits selective increases in expression of 
these matricellular genes remains, however, remains unclear.  Findings from our time-
dependent expression and release studies (Figures 15-17) demonstrate that elevated 
hydrostatic pressure mediated increases in CTGF and ppET-1 mRNA expression and 
protein release occur prior changes in TGF-β2 content. Thus, the possibility that elevated 
hydrostatic pressure increases ppET-1 and CTGF mRNA expression due to TGF-β2 
autocrine signaling appears unlikely. To confirm this supposition, TM cells were pre-
treated (30 min) with 1 µM SB-431542, a TGF-βRII antagonist, and subsequently 
exposed to elevated hydrostatic pressure. Inhibition of TGF- βRII had no effect on 
pressure-induced changes in TGF-β2, CTGF, or ppET-1 mRNA expression (Figure 21).  
An alternative mechanism may involve autocrine signaling by ET-1. Though we have yet 
to examine the effects of ET-1 stimulation on matricellular gene expression in quiescent 
human TM cells, previous findings demonstrate that pressure-induced increases in 
mRNA expression and release of ET-1 occur prior to changes in TGF-β2 content 
(Figures 15, 16). In addition, treatment of vascular smooth muscle cells with exogenous 
ET-1 has been shown to markedly enhance CTGF expression.206  
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Figure 21. Inhibition of ETB receptor activation prevents hydrostatic pressure mediated changes 
in TGF-β2 and ppET-1 mRNA content. Transformed (GTM3) TM cells were pretreated (x30min) 
with either vehicle (0.1% DMSO) or selective receptor antagonists of ETA (BQ-123), ETB (BQ-788), or 
TbRI (SB-431542), as indicated, and subsequently cultured at ambient or elevated pressure (+30 
mmHg, x6h). Relative mRNA content was quantified by qRT-PCR. Data shown are GAPDH-
normalized fold changes from a representative experiment, repeated twice, and expressed as the mean ± 
SEM (N=3). * p <0.05, Student’s t-test relative to ambient pressure control. ** p<0.05, Student’s t-test 
relative to elevated hydrostatic pressure. 
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As such, it is plausible that ET-1 may very well play a role in elevating CTGF mRNA 
and protein content. To determine if ET-1 is acting in such an autocrine manner, 
transformed TM cells were cultured in serum free conditions (x24h), pretreated with 
vehicle or specific ET receptor antagonists (x30min), and subsequently exposed to 
ambient or elevated hydrostatic pressures (+30mmHg, x6h), as indicated (Figure 21). As 
previously demonstrated (Figures 15-17), elevated hydrostatic pressure markedly 
enhanced TGF-β2, CTGF, and ppET-1 mRNA expression (Figure 21 A-C). Pretreatment 
with an ETA (BQ-123) receptor antagonist had no effect on elevated hydrostatic pressure 
mediated increases in TGF-β2, CTGF, or ppET-1 mRNA content. In contrast, 
pretreatment with an ETB (BQ-188) receptor antagonist, or the combination of BQ-123 
plus BQ-188, markedly attenuated elevated hydrostatic pressure mediated increases in 
both TGF-β2 and, surprisingly, ppET-1 mRNA (Figure 21 B, C). By comparison, BQ-
188 had no effect on elevated hydrostatic pressure mediated increases in CTGF mRNA 
expression. These findings support a role for ET-1 autocrine signaling in elevated 
hydrostatic pressure mediated increases in TGF-β2 and ET-1, but not CTGF, mRNA 
expression. These observations, however, await confirmation using primary human TM 
cells.  
 
Canonical TGF-β2 Signaling is not Altered by Elevated Hydrostatic Pressure. 
   It is a prevailing theory that increased levels of TGF-β2 in aqueous humor of 
some POAG patients aberrantly elevates IOP by acting upon the TM to increase actin 
stress fiber formation and altering ECM gene expression and protein remodeling.55, 58, 78, 
99, 209 As shown in Figs. 15 and 16, elevated hydrostatic pressure, in vitro, robustly 
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increases the time-dependent expression and release of both TGF-β2 and CTGF. As a 
known regulator of TGF-β2 signaling, CTGF facilitates binding of TGF-β2 to TGF-βRII, 
promoting smad3 phosphorylation.210 Whereas autocrine signaling of endogenous TGF-
β2 does not play a role in elevated hydrostatic pressure induced changes in CTGF or 
ppET-1 mRNA expression (Figure 21), we considered the possibility that elevated 
hydrostatic pressure itself may potentiate TM cell responses to exogenous TGF-β2 by 
enhancing canonical signaling. To determine if elevated hydrostatic pressure alters TGF-
β2 signaling, transformed TM cells were serum starved (x24h), and treated with vehicle 
or TGF-β2 (5 ng/ml) at ambient or elevated hydrostatic pressure (+30 mmHg, x6h).  
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Figure 22. Elevated hydrostatic pressure does not alter canonical TGF-β2 signaling in human 
TM cells. Transformed (GTM3) human TM cells were serum starved (x24h), and subsequently 
treated with vehicle (200 nM HCl) or TGF-β2 (5 ng/ml) at ambient or elevated pressure (+30 mmHg, 
x6h), as indicated. (A) TGF-β2 mediated smad3 phosphorylation was measured by Western 
immunoblot. (B) Relative changes in mRNA content were quantified by qRT-PCR. Data shown are 
GAPDH-normalized fold changes expressed as the mean ± SEM (N =3) *p<0.05, Two-way ANOVA 
with a Bonferroni’s post hoc analysis.  
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When treated at ambient pressures, transformed TM cells responded to exogenous TGF- 
β2 by modestly increasing smad3 phosphorylation (Figure 22A) without measurably 
altering TGF-β2, CTGF, or ppET-1 mRNA content (Figure 22B). By comparison, while 
exposing TM cells to elevated hydrostatic pressure alone did not initiate smad3 
phosphorylation, it did elicit a significant and very reproducible increase in TGF-β2, 
CTGF, and ppET-1 mRNA content (Figure 22B). The presence of exogenous TGF-β2 
did not, however, alter TM cellular responses to elevated hydrostatic pressure (Figure 
22B) confirming that canonical TGF-β2 signaling is not an early mediator in hydrostatic 
pressure mediated cellular responses. 
 
Elevated Hydrostatic Pressure Increases CTGF, TGF-β2, and ppET-1 mRNA 
Expression Independent of TRPV Mechanosensitive Ion Channels. 
The mechanosensitive ion channel TRPV 4 has been implicated in the regulation 
of AH outflow through the conventional pathway.166 In vitro, inhibition of TRPV4 
prevents formation of actin stress fibers in TM cells induced by mechanical stress.165 
Independent studies have also demonstrated the importance of TRPV1 in pressure-
induced apoptosis in retinal ganglion cells.174 Activation of mechanosensitive ion 
channels, however, is heavily dependent upon shear forces that physically distort the 
plasma membrane and elicit a conformational change in these receptors.207 Given that 
hydrostatic pressure is an isotropic, non-deforming mode of physical stress, the role of 
TRP mechanosensitive ion channels in sensing and responding to elevated hydrostatic 
pressure remains unclear.  
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To determine if elevated hydrostatic pressure elicits changes in gene expression 
through activation of TRPV channels, transformed human TM cells were serum starved 
(x24), pretreated with vehicle or specific TRP channel inhibitors, and subsequently 
cultured at ambient or elevated hydrostatic pressure (+ 30mmHg, x6h), as indicated. As 
we have observed before, compared to ambient pressure controls, elevated hydrostatic 
pressure reproducibly increases the expression of TGF-β2, CTGF, and ppET-1 mRNA 
expression (Fig. 23). Pretreating (x30 min) TM cells with maximally effective 
concentrations of AMG-9810 (a selective TRPV1 antagonist) or HC-067047 (a TRPV4 
antagonist) did not alter elevated hydrostatic pressure mediated changes in TGF-β2, 
CTGF, and ppET-1 mRNA expression (Fig. 23 A-C)Consistent with hydrostatic pressure 
being an isotropic, non-deforming mode of physical stress, these data strongly suggest 
that mechanosensitive TRP ion channels do not play a significant role in the mechanism 
by which transformed human TM cells respond to elevated hydrostatic pressures. The 
possibility that primary human TM cells invoke TRP channels in response to elevated 
hydrostatic pressure, however remote, remains to be evaluated. 
 
Elevated Hydrostatic Pressure Induced Cell Stress Independent of Oxidative Stress. 
It has been well demonstrated that aqueous humor from patients with POAG 
contains increased levels, compared with healthy controls, of superoxide dismutase and 
glutathione peroxidase as well as elevated levels of malondialdehyde (a marker of 
oxidative stress) in their TM.187, 188 More recently it was shown that TGF-β2 expression 
is regulated, at least in part, by ROS208   
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Figure 23. Elevated hydrostatic pressure increases CTGF, TGF-β2, and ppET-1 mRNA 
expression  independent of TRPV channel activation. Transformed (GTM3) human TM cells were 
pretreated x 30min with either vehicle (0.05% DMSO), TRPV 1 (AMG-9810), or TRPV 4 (HC-
067047) channel antagonists, as indicated, and subsequently cultured at ambient or elevated hydrostatic 
pressure (+ 30 mmHg, x6h). Relative mRNA content was quantified by qRT-PCR. Data shown are 
GAPDH-normalized fold changes from a representative experiment, repeated once, and expressed as 
the mean ± SD (N=3). * p <0.05, * Student’s t-test relative to ambient pressure control. 
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Exposing retinal ganglion cells to high levels of elevated hydrostatic pressure, in vitro, 
induces mitochondrial dysfunction and enhances compensatory antioxidant expression.177 
Similarly, previous findings observed here show increased cellular stress in TM cells 
exposed to elevated hydrostatic pressure (Figure 12). Collectively, these results suggest 
that elevated hydrostatic pressure mediated changes in TGF-β2, ET-1, and CTGF mRNA 
expression may result from increased cellular oxidative stress (Figure 15). 
To determine whether oxidative stress plays a role in elevated hydrostatic 
pressure mediated events, transformed TM cells were serum starved (x24), pretreated 
(x24h) with vehicle or with the antioxidants trolox (a water-soluble analogue of α-
tocopherol) or resveratrol (a stilbenoid polyphenol naturally enriched in the skin of 
grapes), and subsequently exposed to ambient or elevated hydrostatic pressure (+ 
30mmHg) for up to 24h, as indicated. Pretreatment with antioxidants alone did not alter 
MTT reduction or increase LDH release (data not shown). Transformed TM cells 
pretreated with trolox and exposed to elevated hydrostatic pressure (1.5h-24h) exhibited 
changes in MTT reduction (Figure 24A), LDH secretion (Figure 24C), and TGF-β2, 
CTGF, and ppET-1 mRNA expression (Figure 24E) that were indistinguishable from 
ambient pressure controls (Figure 24A, C). By comparison, pretreatment with resveratrol 
modestly, yet significantly, protected TM cells against hydrostatic pressure-induced 
decreases in MTT reduction (Figure 24B) and increased LDH secretion (Figure 24D). 
Resveratrol pretreatment, however, failed to protect against elevated hydrostatic pressure 
mediated changes in TGF-β2, CTGF, and ppET-1 mRNA expression (Figure 21F). 
Collectively, these findings argue against oxidative stress playing a major role in the 
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mechanism by which elevated hydrostatic pressure elicits cellular stress and changes in 
gene expression in human TM cells. 
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Figure 24. Elevated hydrostatic pressure induces cell stress independent of oxidative stress. 
Transformed (GTM3) TM cells were conditioned in serum free media (x 24h), pretreated (x30min) with 
either vehicle (0.1% DMSO) or antioxidants as indicated, and subsequently cultured at ambient or 
elevated hydrostatic pressure (+30 mmHg, x6h). Mitochondrial function and membrane permeability 
were quantified by (A, B) MTT reduction and (C, D) LDH release, respectively.  (E, F) Relative 
changes in CTGF, TGF-β2, and ppET-1 mRNA content were quantified by qRT-PCR. Data shown are 
GAPDH-normalized fold changes from 1-2 and expressed as the mean ± SD (N=3-8). * p <0.05, One-
way ANOVA with a Bonferroni’s post hoc analysis. 
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Physiological Consequences of Increased Perfusion Flow Rate on TM Tissue in situ.  
It is well established that different models of mechanical stimuli elicit diverse 
cellular responses, including changes in gene expression.158, 161 While our findings clearly 
show an experimental effect of elevated hydrostatic pressure on cultured human TM 
cells, the physiologic relevance of these in vitro findings must be elucidated to fully 
understand the nature by which aberrantly elevated IOP impacts TM regulated outflow 
facility in patients with POAG. To address the physiological relevance of our findings, 
we examined the effect of increased fluid sheer stress on TM cellular responses in situ 
using anterior segment perfusion. Porcine anterior segments were prepared as described 
in Methods and Materials and allowed to stabilize at physiological perfusion flow rate of 
4.5 µl/min. Following this stabilization period, anterior segments either continued to be 
perfused at physiologic flow rates (4.5 µl/min) or challenged by increasing the perfusion 
flow rate 2-fold (9 µl/min) for up to an additional 24h. At various times (1.5h, 6h, and 
24h), the TM tissue was harvested from perfused anterior segments and changes in 
matricellular gene expression were analyzed. Increasing the perfusion flow rate from 4.5 
ul/min to 9.0 ul/min produced a rapid, yet transient, increase in IOP that peaked within 
1.5h, after which a new, slightly elevated (16 %), steady-state IOP was established 
(Figure 25A), demonstrating the compensatory compliance of the TM to enhanced IOP. 
Exposing TM tissue to increased perfusion flow rates did not appear to alter TM 
cellularity when compared to physiological perfusion flow rate controls (Figure 25 E, F). 
In contrast, time-dependent, differential changes in the content of CTGF and ppET-1 
mRNA expressed by TM tissue, but not TGF-β2 mRNA, were observed in response to 
increased perfusion flow rates. These findings suggest that abrupt and possibly sustained 
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increases in IOP in situ elicits compensatory changes in the conventional outflow 
pathway that may initiate marked changes in TM matricellular and ECM gene 
expression.   
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Figure 25. Physiological consequences of increased perfusion flow rate on TM tissue in situ. 
Porcine anterior segments were allowed to stabilize for 24h, and subsequently perfused at physiological 
(4.5 µl/min) or increased (9 µl/min) perfusion flow n rates for up to an additional 24h. (A) Relative 
changes in IOP in response to increased perfusion flow rates (dashed line = baseline). Data shown are 
normalized to baseline pressure (N=4-9). Porcine TM was removed at 1.5, 6, and 24 hours and relative 
changes in (B) CTGF, (C), TGF-β2 and (D) ppET-1 mRNA content were quantified by qRT-PCR. 
Data shown are GAPDH-normalized fold changes and expressed as the mean ± SEM (N=4-9). * p 
<0.05, Student’s t-test relative to ambient pressure controls. Representative H&E photomicrographs of 
porcine TM infused at (E) physiological and (F) increased perfusion flow rates. 
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CHAPTER 4 
DISCUSSION 
 
Glaucoma is group of optic neuropathies characterized by optic nerve damage 
leading to irreversible blindness. The most prevalent form, POAG, is a slowly 
progressing disease that affects over 60 million worldwide, with this number expected to 
climb to 112 million by the year 2050.1, 2 In the US alone, the socioeconomic cost of 
POAG exceeds 1.9 billion annually , and despite its overwhelming financial burden, 
treatment of POAG remains both refractive and palliative.3 The  pathophysiology of 
POAG is not fully understood and consequently, therapeutic strategies that specifically 
target the underlying causes of this disease of have yet to be developed. Instead, current 
therapeutics are limited to nonspecific forms of intervention designed to lower elevated 
IOP, a major risk factor for the initiation and progression of this disease. This 
pathological elevation of IOP in patients with POAG, is believed to result from increased 
resistance to AH through the TM.10 Reported limitations of all FDA approved drugs for 
the treatment of POAG include decreased efficacy over time, limited bioavailability and 
the need for frequent dosing.211 It is also important to note that no approved therapeutic 
strategy targets the TM itself, instead working by various mechanisms to decrease AH 
production or increase uveoscleral outflow. Thus, the development of novel therapeutic 
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strategies that specifically target the both the TM and the pathogenic causes of POAG are 
necessary to advance patient care. 
The lack of a therapeutic strategy that specifically targets the TM stems, in part, 
from an incomplete understanding of the mechanism by which resistance to AH outflow 
through the TM is elevated. Previous reports have linked this aberrant increased 
resistance to AH outflow to both alterations in the actin cytoskeleton and changes in the 
extracellular milieu of the TM.14, 83, 212, 213 In support of this, post mortem analysis of 
patient TM shows enhanced deposition of sheath-derived plaques as well as a 20-fold 
increase in TM stiffness.39, 51 Experimental evidence suggests a causal role for the 
profibrotic cytokine TGF-β2 in initiating both the formation of actin stress fibers and 
accumulation of ECM, thereby altering TM function and increasing outflow resistance.60, 
63, 99, 214  
Whereas the role of TGF-β2 in elevating IOP has been fairly well studied, the 
effect of elevated pressure on the TM itself is less well understood. An increasing body of 
evidence has shown that the physical properties of a cell’s microenvironment are strong 
determinants of a cell’s behavior.215 The biophysical changes in the TM resulting from 
elevated IOP may be an important upstream factor in the progression of POAG. In this 
regard, TM cells cultured on stiffer substratum (thereby mimicking a glaucomatous 
ECM) respond by enhancing the expression myocilin, CTGF, fibronectin and SPARC, 
four genes implicated in the pathogenesis of POAG.216, 217 Interestingly, TGF-β2 has also 
been demonstrated to elicit increased expression of all four proteins, implying that 
mechanical stimuli may modulate TGF-β2 signaling in TM cells.218, 219 Chronic elevation 
78 
of IOP is known to exert three separate forms of mechanical stimuli upon the TM: 
increased physical stretch, enhanced fluid sheer stress, and elevated hydrostatic pressure. 
In comparison to physical stretch or fluid sheer stress, elevated hydrostatic pressure is the 
least often studied and consequently, least well understood mode of mechanical stress 
experienced by the TM. These, in vitro, studies were designed to: (1) confirm TGF-β2 
induced changes in gene expression in in human TM cells, and (2) characterize TM cell 
responses to elevated hydrostatic pressure. A comprehensive understanding of the 
pathological mechanisms underlying POAG will reveal novel therapeutic targets and 
allow for the advancement of patient care. 
 
TGF-β2 Alters Gene Expression in TM Cells. 
In vitro studies have established TGF-β2 as a key mediator of profibrotic 
signaling, inducing increased expression of matricellular and ECM components in the 
TM.47, 76, 77 Consistent with previous results, TGF-β2 markedly enhanced the expression 
of CTGF mRNA in both primary and transformed TM cells.126, 220 CTGF is known to 
play an essential role in the regulation of tissue repair and fibrosis by integrating 
molecular cues and signals from the ECM to cell surface proteins such as integrins.221, 222 
Adenoviral overexpression of CTGF in the mouse eye induces a glaucomatous 
phenotype, including increased expression of fibronectin and smooth-muscle actin, 
elevated IOP, and optic nerve damage.120 In vitro, CTGF can enhance the expression of 
ECM components and TM cell contractility independent of TGF-β2 signaling.121 To date, 
elevated CTGF content in POAG patient AH has not been reported, although AH samples 
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taken from patients prior to phacoemulsification may not necessarily detect local 
increases in CTGF secretion from the TM. Immunohistochemical analysis of patient TM, 
post mortem, may be a more appropriate method to detect local increases in CTGF 
content in patients with POAG. Collectively, these results suggest an important role for 
CTGF in the pathogenesis of POAG. It is unclear, however, whether CTGF is causative 
or simply an important downstream mediator of TGF-β2 dependent fibrosis in TM of 
POAG patients. 
Not surprisingly, TGF-β2 treatment also elicited a concomitant and selective 
increase in mRNA content of numerous structural ECM protein subunits (Col1α1, 
Col1α2, Col4,) in both primary and transformed TM cells. Transformed (NTM5, GTM3) 
TM cell lines are widely used and generally exhibit characteristics similar to primary TM 
cells. Here, however, we observed a differential response to TGF-β2 in the regulation of 
FN mRNA content. Whenever possible, primary cells were used to confirm results 
originally demonstrated in transformed cell lines. In the event of a differential response 
between primary and transformed cells, the response exhibited by primary TM cells was 
considered more likely to mimic the true phenotype of the TM. Except for certain ECM 
components, no differences in TM cell responses were observed between cell lines. 
TGF-β2 also markedly enhanced ppET-1 mRNA content in both primary and 
transformed human TM cells, though this response was much more robust in transformed 
cells. To date, constitutive expression of ET-1 from TM cells has not been observed. 
Previous findings from our lab have shown, however, that TGF-β2 induces a significant 
increase in ET-1 secretion from TM cells.99  Despite numerous studies, the functional 
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role of ET-1 in regulation of IOP remains unclear. Intravitreal injection of ET-1 into 
Dutch-belted rabbits elicits a transient increase in IOP.113 Similarly, we and others have 
shown that administration of ET-1 to perfused anterior segments transiently increases 
IOP.112 By comparison, ET-1 mediated contraction of the ciliary muscle leads to 
distension of the TM and a subsequent increase in outflow facility.223 In addition, ET-1 
inhibits Na+/K+ ATPases in the nonpigmented ciliary epithelium, decreasing aqueous 
humor production.224 Collectively these results suggests that ET-1 plays a complex role 
in IOP homeostasis, with its functional effect depending upon the location of action. 
Within the TM, ET-1 binds to the ETA receptor, stimulating RhoA GTPase activity and 
contraction of the actin cytoskeleton leading to increased resistance to AH outflow.100 
Interestingly, exogenous TGF-β2 also decreases ETA receptor mRNA in both primary 
and transformed TM cells. ETA receptor expression is regulated by many factors, 
including ET-1 itself.225-227 TGF-β2 may be directly attenuating ETA mRNA content 
either by inhibiting transcription or decreasing ETA receptor mRNA stability. 
Alternatively, secreted ET-1 in response to TGF-β2, may act in an autocrine manner to 
attenuate ETA receptor mRNA. TGF-β2 mediated decreases in ETA receptor content may 
represent a homeostatic mechanism designed to lower IOP by preventing ET-1 mediated 
contraction of the actin cytoskeleton in TM cells. - 
The ETB receptor was not expressed to a measurable extent at the mRNA level in 
vehicle or TGF-β2 treated cells, consistent with previously published studies.108 This is 
most likely a result of the mRNA destabilizing motif “AUUUA” located in the 3’ 
noncoding region of ETB receptor mRNA, resulting in a shortened mRNA half-life.108 
ETB receptor protein however, is expressed constitutively by TM cells although its role in 
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IOP homeostasis is currently not well understood. ETB receptor activity is typically 
thought to increase nitric oxide production leading to vasodilation,102 but also been 
shown to induce contraction in smooth muscle cells.228 Treatment of both bovine and 
human TM cells with the ETB receptor specific agonist IRL-1620 rapidly increases 
intracellular calcium while application of IRL-1620 to isolated bovine TM strips induces 
a small, but detectable, contraction.107 These results suggest that ETB receptor activation 
may induce contraction of the TM, increasing outflow resistance. In human TM cells, 
however, ET-1 activates endothelial nitric oxide synthase by binding to the ETB receptor 
to increase production of nitric oxide.107 While not conclusive, several reports suggest 
that nitric oxide donors may induce relaxation of the TM, decreasing outflow 
resistance.229 As such, the role of ETB receptor in the TM remains unclear. 
 TGF-β2 also markedly attenuated the expression of the B2 receptor in human TM 
cells. BK, a well characterized nonapeptide with potent vasodilatory properties, is known 
to lower IOP in various animal models through activation of the B2 receptor. Earlier 
studies found tissue kallikrein to be present in freshly isolated human TM 95  and kinases 
I and II in human AH.120 Here we demonstrate constitutive expression of the B2, but not 
the B1 receptor, in both primary and transformed TM cells. TGF-b2 mediated decreases 
in B2 receptor content occur through activation of the canonical Smad3 dependent 
pathway, but independent of Rho GTPase signaling. Taken together, these findings 
suggest a role for the local production and action of BK in the TM under normal 
physiological conditions. It has been previously shown that chronic inhibition of 
endogenous BK activity leads to a significant increase in arterial BP.54 Thus, it is 
plausible that elevated content of TGF-β2 in the AH of POAG patients may elevate IOP, 
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in part, by attenuating constitutive B2 receptor expression and activation within the 
conventional outflow pathway.  
 
The Therapeutic Potential of Targeting TGF-β2-mediated Signaling. 
Results shown here conclusively demonstrate that TGF-β2 enhances the mRNA 
expression of specific ECM components, consistent with previous studies.214, 230 We also 
highlighted a unique mechanism by TGF-β2 may elicit an aberrant increase in AH 
outflow resistance, through perturbation of the kallikrein-kinin system. TGF-β2 mediated 
rearrangements in the actin cytoskeleton are also thought to induce elevated IOP in 
patients with POAG.83, 213 Collectively, these results suggest that directly targeting TGF-
β2 may be an effective strategy to lower IOP in patients with POAG. While likely to 
decrease outflow resistance through the TM, directly targeting TGF-β2 could also elicit 
numerous side effects as TGF-β2 is a pleiotropic cytokine involved in a wide variety of 
cellular processes.231  As such, targeting events or functional outcomes that are both 
downstream of initial TGF-β2 mediated signaling, and involved in the pathogenesis of 
POAG represents a more viable therapeutic strategy.  
Here we demonstrate that TGF-β2 markedly enhances mRNA content of CTGF 
and certain structural ECM components and previous studies have shown a direct causal 
link between ECM accumulation and increased outflow resistance.19, 42, 230 Anti-fibrotics, 
therefore, may represent a novel therapeutic strategy to attenuate TGF-β2 mediated 
accumulation of ECM in the TM.  In this regard, the anti-fibrotic agents 5-fluorouracil 
and mitomycin C are commonly used in glaucoma filtration surgery to lower 
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postoperative IOP and prevent scarring.232 More recently, Pattabiraman et al. 
demonstrated that the anti-fibrotic pirfenidone effectively attenuates TGF-β2 mediated 
increases in Col1α1 content in cultured human TM cells.199 These previously published 
results as well as our findings presented here, strongly support the therapeutic potential of 
anti-fibrotics to prevent TGF-β2 mediated accumulation of ECM in the TM.  
TGF-b2 also markedly enhanced ppET-1 mRNA content, and previous studies 
from our lab have demonstrated a concomitant increase in secreted ET-1 from human TM 
cells.99 ET-1, a potent vasoconstrictor, enhances formation of actin stress fibers and 
elevates IOP through activation of the small, monomeric, GTPase RhoA. Administration 
of inhibitors of the Rho effector molecule, Rho kinase (ROCK), inhibits the formation of 
F-actin reducing outflow resistance through the conventional pathway.89, 199 Not 
surprisingly, several inhibitors of the Rho effector molecule, ROCK, are currently in 
either Phase II or Phase III clinical trials.233 While initial results of these trials seem 
promising, it is also important to note that a large number ROCK inhibiting compounds 
have already failed to pass clinical trials, typically due an inability lower IOP over long 
periods of time. In addition, ROCK inhibitors would be unlikely to protect against TGF-
β2 mediated changes in B2 receptor content as this occurs selectively, through the 
canonical smad3-dependent pathway. Thus, while promising, the long term clinical 
efficacy of ROCK inhibitors remains uncertain. 
BK itself represents a potential therapeutic strategy for patients with POAG due to 
its ocular hypotensive effects. Exogenous BK significantly increases outflow facility in 
both bovine129 and human131 anterior segment perfusion. Similarly, intravitreal injection 
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of BK into Dutch-Belted rabbits with naturally high IOP significantly decreases IOP130, 
although this effect is transient. The recent discovery of the non-peptide BK analogue 
FR-190997 may represent a hypotensive agent with more favorable pharmacokinetic 
properties.29 Previous studies demonstrating the therapeutic efficacy of BK or FR-
190997, however, did not account for the TGF-β2 mediated perturbation of the kallikrein-
kinin system. It is plausible that elevated content of TGF-β2 present in POAG patient AH 
may reduce B2 receptor content in the TM, reducing the hypotensive effect of both BK 
and FR-190997.   
While each of these therapeutics represents a novel and promising therapeutic 
strategy, a better understanding of the underlying mechanisms involved in the 
pathogenesis of POAG is necessary to truly advance patient care. To this end, we sought 
to elucidate the cellular response and mechanism of action of elevated hydrostatic 
pressure on TM cells, and how this unique mechanical stimulus may initiate a feed-
forward loop that further elevates IOP. 
 
Elevated Hydrostatic Pressure Induces Cell Stress and Apoptosis in TM Cells.  
TM cells are known to sense and respond to fluctuations in IOP caused by 
blinking, eye movement, or ocular pulse. It has been well demonstrated that transient 
elevations in IOP elicit changes in ECM turnover and alterations in the actin cytoskeleton 
leading to decreased resistance to AH outflow.153, 154 The effect of prolonged mechanical 
stress on the TM as result of elevated IOP, however, is not as well understood.  Neuronal 
PC12 cells exposed to extremely elevated hydrostatic pressures tend to exhibit 
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characteristic markers of oxidative stress and apoptosis.180 Similarly, we demonstrate that  
a sustained (x24h) exposure of cultured human TM cells to elevated hydrostatic pressure 
elicits mitochondrial dysfunction, as measured by the MTT assay. In addition, cleavage 
of caspase 3, a characteristic marker of apoptosis, was observed following even more 
prolonged exposure (~48h) to elevated hydrostatic pressure. Patients with POAG are 
known to exhibit decreased TM cellularity, when compared to healthy individuals ,which 
is thought to contribute to elevated AH outflow resistance.234 These findings suggest that 
prolonged exposure to elevated hydrostatic may induce TM cell apoptosis in patients with 
POAG.  
 
Elevated Hydrostatic Pressure Alters the Actin Cytoskeleton in TM Cells. 
Prior to onset of apoptosis, TM cells are known to respond to mechanical stimuli 
by altering their cytoskeletal network and cell shape.198 Enhanced organization of the 
actin cytoskeleton of TM cells, especially in the JCT area, is known to increase outflow 
resistance through the conventional pathway leading to elevated IOP.235 When 
mechanical stretch is applied to TM cells, in vitro, stress fibers form parallel to the 
direction of stretch.236 Actin stress fiber formation is correlated with TM tissue stiffness 
and enhanced resistance to aqueous humor outflow.237 Elevated hydrostatic pressure has 
also been shown to modulate cytoskeletal elements eliciting increased expression of heat-
shock protein-27 in human astrocytes leading to stabilization of intermediate filaments 
networks.172 The effect of elevated hydrostatic pressure on the cytoskeletal network of 
TM cells, however, has not been previously reported.  
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Here we demonstrate a marked accumulation in F-actin in response to elevated 
hydrostatic pressure. The balance between the assembly of globular (G)-actin into F-
actin, and subsequent disassembly back into G-actin, directly affects the activity and 
subcellular localization of actin binding proteins and certain transcription factors.238 
Actin binding proteins have been shown to stimulate or inhibit steroid receptor hormones, 
indirectly regulating transcription.239 A shift in G/F actin ratio in TM cells following 
exposure to elevated hydrostatic pressure could indirectly regulate gene transcription by 
enhancing or inhibiting the activity of various actin binding proteins. Altered expression 
of nuclear actin was not observed in response to elevated hydrostatic pressure, but 
phalloidin cannot always detect nuclear actin. It seems unlikely that elevated hydrostatic 
pressure enhanced cytoplasmic F-actin content without a concomitant change in nuclear 
actin occurring. Nuclear actin has been demonstrated to play integral role in 
transcriptional regulation as it is (1) utilized by all three nuclear RNA polymerases,240 (2) 
may affect mRNA processing by associating with small nuclear ribonucleoproteins,241, 242 
(3) and is an essential component of chromatin-remodeling and histone acetyl transferase 
complexes.243 Thus it is plausible that hydrostatic pressure mediates changes in the actin 
content may play a more direct role in regulating gene expression by interacting directly 
with the machinery necessary for transcription. 
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Elevated Hydrostatic Pressure Elicits Selective Changes in Gene Expression in TM 
Cells. 
Using a predesigned “POAG” nanoarray, we confirmed that elevated hydrostatic 
pressure induces marked changes in the gene expression of TM cells. Of the 16 genes 
measured, each of which has been previously indicated in the pathogenesis of POAG, 
only CDKN1A, VEGF-A, and CTGF mRNA content were significantly enhanced in 
response to elevated hydrostatic pressure. While this result clearly underrepresents the 
true number of genes affected, it does demonstrate, for the first time, that hydrostatic 
pressure elicits specific changes in gene expression.  
CDKN1A is well known to inhibit cyclin dependent kinases, causing irreversible 
arrest of the cell cycle.244 A single nucleotide polymorphism (SNP) in this protein 
encoding a DNA-binding zinc finger domain is correlated with the prevalence of POAG 
in a specific Chinese population.245 This SNP prevents CDKN1A from binding to its 
target, sensitizing cells to apoptosis. While elevated hydrostatic pressure did elicit a small 
increase in CDKN1A mRNA content, it is unlikely to affect CDKN1A function. Pressure 
mediated increases in CDKN1A mRNA would have no effect on CDKN1A binding to its 
target, and thus would be unlikely to sensitize TM cells to apoptosis. As such, the 
physiological relevance of this finding remains uncertain. 
Cultured TM cells also exhibited a transient increase in VEGF-A mRNA in 
response to elevated hydrostatic pressure. VEGF-A has been previously implicated in 
initiating and controlling the progression of a secondary form of glaucoma, neovascular 
glaucoma.201 Patients with this disease exhibit a 40-fold increase in VEGF-A content in 
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their AH, compared to healthy controls.201 This trend, however, is not reflected in POAG 
patient AH, and as such, the role of VEGF-A in POAG is less clear. In some patients with 
age-related macular degeneration, anti-VEGF therapy induces elevated IOP suggesting 
that VEGF-A may have hypotensive effects.202 Supporting this, administration of VEGF-
A, ex vivo, increases outflow facility in perfused porcine anterior segments.200  Recently, 
Micera et al. examined differential protein expression in TM tissue isolated from 
medically managed POAG patients and healthy control samples. This study is somewhat 
unique in that most gene and proteomic studies are conducted on TM tissue acquired post 
mortem. In this study, TM was acquired from POAG patients undergoing 
trabeculectomies and 46 differentially expressed proteins were identified including 
VEGF-A.246 This implies that not only is VEGF-A constitutively expressed by the TM, in 
vivo, but upregulated in patients with POAG.246 Interestingly, mechanical stretch has 
been  shown to enhance VEGF-A secretion from TM cells.247 While the TM is known to 
express VEGF receptors, administration of exogenous VEGF-A to TM cells does not 
significantly alter transendothelial electrical resistance (TEER).200 In contrast, treatment 
of SC endothelial cells with VEGF-A markedly decreases TEER, enhancing cell 
permeability.  Thus, elevated hydrostatic pressure mediated increases in VEGF-A from 
the TM may represent a compensatory mechanism that lowers outflow resistance by 
allowing AH to more easily cross the endothelial lining of SC  
 
 
89 
Elevated Hydrostatic Pressure Elicits a Sustained Increase in CTGF mRNA content 
and Protein Secretion. 
Elevated hydrostatic pressure markedly enhanced the synthesis and secretion of 
CTGF, despite this matricellular protein already being one of the most highly expressed 
genes in the TM.248 Constitutive expression of CTGF is necessary for proper maintenance 
of the actin cytoskeleton and ECM turnover.248 By comparison, enhanced expression of 
CTGF in the TM may be a primary protective response to oxidative stress.248 The TM is 
highly susceptible to oxidative damage due to diminished antioxidant defenses,186, 189 and 
TGF-β2, a potent inducer of CTGF, is well known to regulate reactive oxygen species 
production.249 In experimental models of diabetic neuropathy, increased oxidative stress 
is typically paralleled by enhanced CTGF expression, suggesting a protective role for 
CTGF.250 In this regard, supplementation with CTGF prior to oxidative insult has been 
shown to be beneficial to TM cell viability, in vitro, while targeted knockdown of CTGF 
expression prior to a oxidative insult results in increased cell death.118  Collectively, these 
findings suggest that a rapid increase in CTGF expression represents an important 
protective mechanism designed to protect against oxidative or other forms of cell stress. 
Adenoviral overexpression of CTGF, however, promotes a glaucomatous phenotype 
including elevated IOP, alterations in the actin cytoskeleton, enhanced deposition of 
ECM components, and optic nerve damage.120, 121 Therefore, a sustained increase in 
CTGF content as a result of elevated hydrostatic pressure, as demonstrated here, may 
ultimately lead to enhanced resistance to aqueous humor outflow through the TM. 
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Elevated Hydrostatic Pressure Transiently Increases TGF-β2 Content. 
Elevated hydrostatic pressure also markedly increased the synthesis and secretion 
of TGF-β2 from TM cells in a time-dependent manner. It is well established that TGF-β2 
content is elevated in the AH of patients with POAG.55, 57-59 Post mortem analysis has 
localized TGF-β2 expression to multiple tissues in the anterior chamber including lens 
epithelial cells, conjunctival stroma, the ciliary body, and the TM itself.67, 68 Previous 
studies from our lab clearly demonstrate constitutive synthesis and secretion of TGF-β2 
from both primary and transformed TM cells suggesting that the source of elevated TGF-
β2 in patient AH may be the TM itself.60  The mechanisms governing pressure mediated 
increases in TGF-β2 are unknown but most likely involve both increased Rho GTPase 
activity and histone acetylation. Inhibition of the small monomeric Rho GTPases, RhoA 
markedly attenuates constitutive secretion of TGF-β2 from TM cells.75 In contrast, TGF-
β2 expression is enhanced by hyperacetylation of histones associated with the TGF-β2 
promoter.80 Interestingly, fluid sheer stress is known to modulate both HDAC and Rho 
GTPase activity in vascular endothelial cells.251, 252 Elevated hydrostatic pressure may 
have a similar effect in TM cells, enhancing Rho GTPase activation and histone 
acetylation leading to increased TGF-β2 expression.  
 
ET-1 Synthesis and Secretion is Enhanced in Response to Elevated Hydrostatic 
Pressure. 
 Similar to TGF-β2 and CTGF, ET-1 synthesis and secretion from the TM was 
markedly upregulated in a time-dependent manner in response to elevated hydrostatic 
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pressure. The local production of ET-1 would most likely induce a marked contraction of 
the actin cytoskeleton, enhancing AH outflow resistance. In this regard, elevated 
hydrostatic pressure did significantly alter F-actin expression as previously discussed. 
There was also a significant decrease in ETA mRNA content in response to elevated 
hydrostatic pressure (x24h). Decreased ETA receptor mRNA content may represent a 
homeostatic mechanism designed to lower IOP by decreasing ET-1/ETA receptor 
mediated contraction of the actin cytoskeleton. While elevated hydrostatic pressure may 
be affecting ETA receptor content directly, this effect observed may also be a result of 
secreted TGF-β2 or ET-1 acting in an autocrine manner 
 
Elevated Hydrostatic Pressure Elicits Altered Expression of Proteases in Primary 
TM Cells. 
 As both TGF-β2 and CTGF secretion was enhanced in response to elevated 
hydrostatic pressure, it is logical to assume that there may have been a similar response in 
ECM production. To this point, primary TM cells exposed to elevated hydrostatic did 
elicit a significant, yet transient increase in various structural ECM protein subunits in 
primary TM cells. Transformed TM cells, however, typically did not exhibit similar 
responses, and as such, the relevance of these findings is unclear. It is still plausible that 
elevated hydrostatic pressure may affect ECM protein content without significantly 
altering gene expression, by either inhibiting or promoting ECM degradation. 
Alternatively, elevated hydrostatic pressure may alter the transcription of genes relevant 
to ECM remodeling such as growth factors, proteases, and inhibitors of proteases. 
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Interestingly, exposure to elevated hydrostatic pressure markedly enhanced the 
expression of both MMP3 and PAI-1 mRNA from primary TM cells, both of which have 
been previously indicated in the pathogenesis of POAG. These results suggest that 
elevated hydrostatic pressure markedly affects the extracellular milieu of TM cells. By 
altering ECM turnover. Further studies are warranted to further elucidate the effect of 
elevated hydrostatic pressure on ECM proteins and aqueous humor outflow through the 
TM. 
 
TM Cells Respond to Elevated Hydrostatic Pressure by Increasing Bradykinin B1 
Receptor mRNA Expression.  
  Elevated hydrostatic pressure induced a marked, yet transient, increase in B2 
receptor mRNA in primary TM cells. In contrast, B1 receptor mRNA expression in 
primary TM cells was enhanced in a sustained manner. We and others have shown that 
specifically in TM cells, the B1 receptor protein is not expressed to a measurable extent 
at the protein level and application of B1 receptor specific agonists fail to elicit a 
functional outcome.29, 130  Expression of the B1 receptor in other tissues, however, is 
strongly upregulated following exposure to trauma, inflammation, or certain cytokines 
(tumor necrosis factor-α, IL-1β, and IL-8).139, 253  The marked increase in B1 receptor 
mRNA observed implies that there may be a similar increase in B1 receptor protein. The 
B1 receptor is typically coupled to the same intracellular signaling cascades as B2 
receptor.254 As such, the B1 receptor is known to activate protein kinase C, tyrosine 
kinase cascades, and the MAPK pathway, induce nuclear translocation of NF-κB, and 
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stimulate PI hydrolysis.133 Activation of B1 receptor, however, does tend to elicit a much 
different pattern of intracellular signaling when compared to B2 receptor, mostly due to 
differences in receptor internalization patterns.  The B2 receptor is normally expressed in 
a number of tissues, and present on the plasma membrane in the absence of its agonist, 
BK. Following binding of BK, however, the B2 receptor undergoes rapid internalization 
in clathrin-dependent manner.255 In contrast, binding of agonists to the B1 receptor 
actually reduces the rate of receptor internalization from the plasma membrane.255 BK is 
potent yet short lived hypotensive agent that acts by binding to the B2 receptor. If B1 
receptor protein expression is in fact enhanced in the TM in response to elevated 
hydrostatic pressure, B1 agonists may have a more prolonged hypotensive effect.  Further 
studies are warranted to characterize kallikrein-kinin system, specifically the B1 receptor, 
under hypertensive conditions.  
 
TM Cells are Sensitive to Clinically Relevant Changes in Hydrostatic Pressure.  
Findings presented here clearly demonstrate that elevated hydrostatic pressure 
induces cellular stress leading to apoptosis, enhances F-actin content, and selectively 
alters gene expression in human TM cells, each of which may contribute to the aberrant 
elevation of IOP in patients with POAG. When considering the relevance of these 
findings, however, it is important to note the difference between physiological and 
pathological levels of hydrostatic pressure. In these studies, +30 mmHg was chosen to 
mimic a hydrostatic pressure load similar to that experienced by patients with POAG.    
Application of increasing levels of hydrostatic pressure, however, has been previously 
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demonstrated to elicit a differential cellular response, somewhat mimicking a 
pharmacological dose response to a drug or ligand.203, 204 By comparison, we did not 
observe any significant differences in magnitude of TM cell responses to increasing 
hydrostatic pressures(+ 15-45 mmHg). It should be noted that the high pressure condition 
(+45 mmHg) was less than the hydrostatic pressure loads most commonly used in 
experiments in other ocular tissues (60-100 mmHg).174, 182 TM cells may exhibit 
differential responses when subjected to a larger range of hydrostatic pressures. By 
comparison, hydrostatic pressure loads as low as +15 mmHg are rarely used in an 
experimental setting, but would represent a marked increase in vivo. A recent study found 
an average increase of only 8.8 mmHg in the IOP of patients with POAG when compared 
to healthy, age-matched controls.256 While caution should always be used in extrapolating 
results obtained in vitro to in vivo situations, these findings do indicate that TM cells may 
be remarkably sensitive to clinically relevant changes in hydrostatic pressure. Thus, the 
magnitude of increased IOP exhibited by patients with POAG may elicit a similar 
increase in the synthesis and secretion of matricellular proteins from TM cells as 
observed here. 
 
The Role of the ETB Receptor in Elevated Hydrostatic Pressure Mediated Changes 
in Gene Transcription. 
As both TGF-β2 and ET-1 have been shown to induce CTGF expression,126, 220, 257	
it is plausible that each may play a role in upregulating matricellular gene expression in 
response to elevated hydrostatic pressure. Pretreatment with specific antagonists to the 
95 
ETA receptor or TGF-βRII however, did not have a significant effect upon changes in 
gene transcription observed. In contrast, a specific antagonist to the ETB receptor 
markedly attenuated hydrostatic pressure mediated increases in both TGF-β2 and ppET-1 
mRNA.  Although TM cells do not constitutively secrete ET-1, we have demonstrated 
that elevated hydrostatic pressure induces secretion of ET-1 within 3 hours of exposure. 
Collectively these results suggest that secreted ET-1 may bind to the ETB receptor in an 
autocrine manner, potentiating transcription of TGF-β2 and ppET-1. While the role of the 
ETB receptor in IOP homeostasis remains unclear, recent evidence suggests that ETB 
receptor may be a key contributor to RGC cell death in patients with POAG.103 Post 
mortem analysis of glaucomatous tissue shows increased ETB receptor immunoreactivity 
in optic nerve head astrocytes.258 Similarly, ETB receptor expression is increased in areas 
of degeneration that colocalize with astrocytic markers in a non-human primate model of 
glaucoma.258  In vitro, treatment of primary RGCs with ET-1 or ET-3, a selective ETB 
receptor agonist, induces apoptotic cell death to a similar extent.103  In vivo, treatment 
with the combination ETA/ETB receptor inhibitor bosentan protects against axonal 
degeneration in the DBA/2J mouse model of glaucoma.259   In Morrison’s ocular 
hypertension model, ETB receptor expression in the nerve fiber and retinal ganglion cell 
layer is markedly upregulated prior to the onset of axonal degeneration.104  Furthermore, 
selective knockout of ETB receptor enhances RGC survival in this same model. Elevated 
IOP in patients with POAG, therefore, may enhance the expression and subsequent 
activation of ETB in the retina, contributing to RGC cell death in POAG.   A similar 
increase in ETB receptor content or activation in the TM may contribute to hydrostatic 
pressure mediated apoptosis, ultimately leading to the decreased TM cellularity observed 
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in POAG patients.  While elevated hydrostatic pressure markedly attenuated ETA 
receptor mRNA content, changes in ETB receptor mRNA content were not observed. 
Further studies are warranted to more fully characterize the effect of elevated IOP on ETB 
receptor expression and function in the conventional pathway. 
 
Elevated Hydrostatic Pressure Does not alter TGF-β Signaling in TM Cells. 
While it is clear that pressure mediated changes in gene expression in TM cells 
does not involve, at least initially, activation of TβRI, it still seemed plausible that 
elevated hydrostatic pressure may modulate TGF-β2-mediated signaling.  Exposure of 
TM cells to elevated hydrostatic pressure, however, failed to induce smad3 
phosphorylation. In addition, pretreatment with exogenous TGF-β2 had no observable 
effect upon pressure mediated changes in mRNA content. Collectively, these results 
suggest that elevated hydrostatic pressure mediated does not alter TGF-β2 signaling. 
Increased secretion of active TGF-β2 however, does not occur prior to 24h exposure to 
elevated hydrostatic pressure. As secreted ET-1 has been shown to acts in an autocrine 
manner to enhance ppET-1 and TGF-β2 mRNA transcription, it seems likely that 
secreted TGF-β2 may also elicit autocrine effects following a more prolonged exposure.  
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The Role of Reactive Oxygen Species in Cellular Responses to Elevated Hydrostatic 
Pressure. 
Post mortem analysis of glaucomatous tissue suggests role of ROS in the 
pathogenesis of POAG as markers of oxidative stress including increased end-product 
lipid peroxidation and oxidative DNA damage in patients with POAG.184, 185 Optic nerve 
head astrocytes exposed to elevated hydrostatic pressure display decreased mitochondrial 
fission, indicative of oxidative stress.179, 182  More recently, it was shown that both CTGF 
and TGF-β2 expression are regulated, at least in part, by ROS. 208, 221 As such, it seemed 
plausible that the mitochondrial dysfunction and cell death, changes in F-actin content, 
and alterations in gene expression observed here may have resulted from increased ROS 
induced by elevated hydrostatic pressure. 
To clarify the role of oxidative stress, TM cells were pretreated with two different 
antioxidants, and subsequently exposed to elevated hydrostatic pressure. Pretreatment 
with the antioxidant Trolox did not significantly alter pressure mediated changes in 
mitochondrial function, membrane permeability, or gene transcription. By comparison, 
resveratrol did have a slight, but significant protective effect, delaying changes 
mitochondrial function and membrane permeability. Elevated hydrostatic pressure 
mediated changes in gene expression, however, were not significantly altered by 
resveratrol. Taken together, these results suggest that oxidative stress does not play a 
significant role in the observed findings presented here. It is possible that the dose of 
antioxidants used here were simply insufficient to protect against the amount of oxidative 
damage induced by elevated hydrostatic pressure. Alternatively, prolonged exposure 
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(48h) to antioxidants themselves may act as a unique insult, sensitizing cells to oxidative 
stress. This is unlikely however, as resveratrol and Trolox by themselves did not 
significantly affect MTT formation or LDH release compared to ambient pressure 
controls. In addition to its antioxidant properties, resveratrol is also known to be anti-
inflammatory and anti-proliferative due to its modulation of NF-κB, p53, bcl2, and the 
inhibitor of HDAC, sirtuin1.260 Thus resveratrol may be delaying deficits in 
mitochondrial function by a mechanism that is independent of oxidative stress.  
 
TM Cells Respond to Elevated Hydrostatic Pressure by a Mechanism Independent 
of TRPV Channel Activation. 
 Previous studies conducted in other cell types have examined the downstream 
cellular effects of hydrostatic pressure, but little is known about the mechanism by which 
cells sense and respond to this stimulus. Ryskamp et al. recently identified the putative 
mechanosensitive ion channel TRPV4 as a key transducer of mechanical stretch in TM 
cells.165 In support of this, both selective TRPV4 agonists and substrate stretch enhance 
F-actin formation in primary TM cells.165 By comparison, topical administration of a 
TRPV4 antagonist simultaneously lowers IOP and protects against retinal damage in a 
mouse model of glaucoma. Alternatively, TRPV1 has been shown to be a key transducer 
of hydrostatic pressure in microglia and retinal ganglion cells, in vitro.174 The principal 
mechanism of TRPV channel activation involves changes in plasma membrane tension, 
either as a result of fluid sheer stress or cell swelling/shrinking, leading to a 
conformational change and subsequent influx of Ca2+ or other cations.207 As hydrostatic 
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pressure is an isotropic, nondeforming mode stress, it is unlikely to activate TRPV 
channels by inducing membrane deformation. However, recent evidence has 
demonstrated that additional diverse stimuli including phorbol esters, metabolites of 
arachidonic acid, acidity, and capsaicin can also activate these channels.207 Consequently 
while a role for TRPV1 and TRPV4 channels in TM cells in sensing and responding to 
elevated hydrostatic pressure does not seem likely, it could not be ruled out. Here, we 
demonstrate that specific TRPV1 and TRPV4 antagonists have no effect upon pressure 
mediated changes in gene transcription. This strongly supports the hypothesis that 
mechanosensation of hydrostatic pressure in TM cells is independent of TRPV 1 and 4 
activation. 
 
Incorporating Hydrostatic Pressure into the Tensegrity Model of 
Mechanosensation. 
 An alternative mechanism by which TM cells may sense elevated hydrostatic 
pressure involves a concept of cellular and tissue mechanotransduction known as the 
tensegrity model. This model views the ECM and cells within a tissue as one continuous 
network.261 The ECM is physically linked to the internal cytoskeletal lattice by 
transmembrane adhesion complexes, predominantly integrins, mechanically coupling the 
extracellular environment to the intracellular cytoskeletal scaffold.261 Within an 
individual cell, cytoskeletal elements (microtubules, intermediate filaments, and actin) 
simultaneously generate and resist mechanical forces determining cell shape while 
providing a framework for cytokinesis, intracellular communication, and the trafficking 
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of organelles, vesicles and proteins. When a traditional, deforming stimuli is applied to a 
tissue, force is distributed across the continuous network of ECM fibers and subsequently 
transmitted by transmembrane adhesion complexes to intracellular, load-bearing 
cytoskeletal elements.261 This change in intracellular tension can alter the state or 
polymerization of microtubules, intermediate filaments, and actin. Actin dynamics in 
turn, have been shown to regulate the localization of some transcription factors and actin 
binding proteins. For example, myocardin-related transcription factors (MRTFs) are 
typically sequestered in the cytoplasm, associated with G-actin.262 Following mechanical 
stimulation and actin polymerization, MRTF translocates to the nucleus and associates 
with serum response factor to initiate transcription.263 Within the context of systemic 
scleroderma, MRTF expression and nuclear translocation has been implicated in 
maintaining a feedforward loop of increased contractility and matricellular protein 
expression leading to further mechanical stress and ECM modification.262 Within the TM, 
the interaction between serum response factor and MRTF is critical to RhoA induced 
expression of profibrotic genes.199 Here we demonstrated that elevated hydrostatic 
pressure elicits a marked accumulation of intracellular F-actin. This shift in actin 
dynamics most likely modulates the subcellular localization of transcription factors 
including MRTF, leading to the enhanced expression of matricellular genes observed 
here.  
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The Physiological Consequences of Increased Perfusion Flow Rate on the TM. 
The TM experiences many different types of mechanical stress including fluid 
and in vitro modeling of each of these mechanical stimuli often results in unique and 
sometimes conflicting outcomes.  This simultaneously enhances the difficulty of 
extrapolating in vitro cellular responses to mechanical stress to an in vivo situation, and 
increases the importance of comparing the effects of multiple mechanical modalities.  To 
this end, we examined the effect of increased fluid sheer stress on matricellular gene 
expression in porcine TM cells. Increased perfusion flow rate elicited an immediate 
increase in pressure, as expected. After 1.5h, however, pressures began to decline before 
stabilizing 16% above baseline. TM cells initially respond to elevated IOP by altering 
ECM turnover in order to lower outflow resistance.19 This homeostatic response is clearly 
demonstrated by the decrease in pressure observed following 1.5h of increased perfusion 
rate. Similarly, Vittal et al. demonstrated that perfusion of human anterior segments at 
high pressures increases MMP2, lowering outflow resistance.46 In contrast to the effects 
of elevated hydrostatic pressure on TM cells, we did not observe any significant changes 
in TGF-β2 mRNA content in response to increased fluid shear stress in porcine anterior 
segments. There was also a statistically significant decrease in ppET-1 and CTGF 
mRNA. Attenuated expression of CTGF and ppET-1 represents yet another rapid, 
homeostatic response designed to lower outflow resistance similar to that previously 
demonstrated by Vittal et al.  Evidence suggests, however, that increased deposition of 
ECM components and enhanced TM stiffness occur only after chronic over activation of 
this homeostatic response. It is plausible that a more prolonged exposure to high 
perfusion rates may elicit enhanced expression of matricellular proteins that more closely 
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mirrors the observed effects of elevated hydrostatic pressure on TM cells, in vitro. 
Furthermore, as fluid sheer stress and hydrostatic pressure are most likely detected by 
different mechanisms, it is logical each mechanical stimulus may elicit unique responses. 
To this point, it has recently been demonstrated that multimerization of the ECM protein 
cochlin and subsequent functional interaction with TREK-1 is involved in fluid shear 
stress dynamics in the TM.264 To date, however, no link has been demonstrated between 
elevated hydrostatic pressure and cochlin or TREK-1. Alternatively, perfusion of anterior 
segments at elevated pressures has been shown to induce differential regulation of 
collagens and matricellular proteins indicating increased fluid sheer stress may influence 
the expression of genes also regulated by hydrostatic pressure265, 266 Findings presented 
here clearly demonstrate that two types of mechanical stimuli experienced by the TM, 
fluid sheer stress and hydrostatic pressure, regulate CTGF and ET-1 expression in the 
TM.  
 
Summary and Conclusion. 
 In this thesis, three unique mechanisms by which TGF-β2 elicits elevated IOP in 
patients with POAG are detailed. (1) TGF-β2 was found to markedly enhance the 
expression of matricellular and structural ECM genes, (2) TGF-β2 simultaneously 
induces increases in the expression of the potent vasoconstrictor ET-1, and (3) TGF-β2 
was found to attenuate constitutive expression of Bradykinin B2 receptor (Figure 26). 
Each of these mechanisms represents a novel target for the therapeutic management of 
IOP in patients with POAG. Previously published studies have also shown TGF-β2 
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Figure 26: Mechanism by which TGF-β2 elevates IOP and subsequent TM cellular responses. 
capable of altering the actin cytoskeleton. As a result, ROCK inhibitors, which reversibly 
induce actin depolymerization, are also currently being considered as therapeutic strategy 
for the management of IOP in patients with POAG.  
 A clear understanding of the underlying signaling events relevant to the 
pathogenesis of POAG is necessary to truly advance patient care. To better understand 
the role that elevated hydrostatic pressure may play in POAG, we characterized the 
response of TM cells to this unique mechanical stimulus. Elevated hydrostatic pressure 
induced cellular stress leading to apoptosis, alterations in the actin cytoskeleton, and 
selective and time-dependent changes in gene expression. Most notably TM cells exposed 
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to elevated hydrostatic pressure exhibited a transient increase in TGF-β2 and ET-1 
content as well as a sustained increase in CTGF expression. The mRNA expression of 
several proteases (Table 5) involved in ECM remodeling was also enhanced, suggesting 
that elevated hydrostatic pressure may lead to ECM dysregulation. The mechanism by 
which TM cells sense and respond to hydrostatic pressure remains unknown but data 
presented here suggests that this mechanism is independent of TRPV channel activation, 
TGF-β2 signaling, or oxidative stress. By comparison, activation of ETB receptor 
potentiates pressure mediated changes in TGF-β2 and ppET-1 content indicating this 
receptor may be involved.  
Collectively, our findings suggest that elevated hydrostatic pressure may initiate a 
feed-forward loop by enhancing local secretion of matricellular proteins, enhancing F-
actin content, altering the extracellular milieu, and decreasing TM cellularity ultimately 
leading to further enhanced resistance to AH outflow through the conventional pathway. 
The use of targeted therapeutics such as ROCK inhibitors, anti-fibrotics, or even ETB 
receptor antagonists to interrupt this cycle may represent a novel viable strategy b which 
to lower IOP in affected POAG patients 
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